# The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification

Sedigheh Delmaghani, Aziz El-Amraoui

► To cite this version:

Sedigheh Delmaghani, Aziz El-Amraoui. The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification. Human Genetics, 2022, 141 (3-4), pp.709-735. 10.1007/s00439-022-02448-7. pasteur-03916414

HAL Id: pasteur-03916414

https://pasteur.hal.science/pasteur-03916414

Submitted on 30 Dec 2022

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
# The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification

Sedigheh Delmaghani<fnref n="1" /> Ⓓ · Aziz El-Amraoui<fnref n="1" /> Ⓒ

Received: 23 February 2022 / Accepted: 4 March 2022 / Published online: 30 March 2022
© The Author(s) 2022

## Abstract

Usher syndrome (USH) is the most common cause of deaf-blindness in humans, with a prevalence of about 1/10,000 (~400,000 people worldwide). Cochlear implants are currently used to reduce the burden of hearing loss in severe-to-profoundly deaf patients, but many promising treatments including gene, cell, and drug therapies to restore the native function of the inner ear and retinal sensory cells are under investigation. The traditional clinical classification of Usher syndrome defines three major subtypes—USH1, 2 and 3—according to hearing loss severity and onset, the presence or absence of vestibular dysfunction, and age at onset of retinitis pigmentosa. Pathogenic variants of nine USH genes have been initially reported: *MYO7A*, *USH1C*, *PCDH15*, *CDH23*, and *USH1G* for USH1, *USH2A*, *ADGRV1*, and *WHRN* for USH2, and *CLRN1* for USH3. Based on the co-occurrence of hearing and vision deficits, the list of USH genes has been extended to few other genes, but with limited supporting information. A consensus on combined criteria for Usher syndrome is crucial for the development of accurate diagnosis and to improve patient management. In recent years, a wealth of information has been obtained concerning the properties of the Usher proteins, related molecular networks, potential genotype–phenotype correlations, and the pathogenic mechanisms underlying the impairment or loss of hearing, balance and vision. The advent of precision medicine calls for a clear and more precise diagnosis of Usher syndrome, exploiting all the existing data to develop a combined clinical/genetic/network/functional classification for Usher syndrome.

## Introduction

Usher syndrome (USH) is the most common hereditary form of deaf-blindness, with a global prevalence of 4 to 17 cases per 100,000 individuals; it accounts for more than half of all hereditary cases of deaf-blindness and 3–6% of all cases of childhood hearing loss (Hope et al. 1997; Kimberling et al. 2010). This syndrome was first described by Albrecht von Graefe in 1858, but was named after Charles Usher, a Scottish ophthalmologist, who was the first to report its hereditary nature (Bonnet and El-Amraoui 2012; El-Amraoui and Petit 2005; Friedman et al. 2011; Kremer et al. 2006). It

displays autosomal recessive inheritance and is clinically characterized by the combination of sensorineural hearing loss (SNHL) and rod-cone dystrophy or retinitis pigmentosa (RP), and variable vestibular dysfunction (Castiglione and Moller 2022; El-Amraoui and Petit 2014; Geleoc and El-Amraoui 2020; Kremer et al. 2006; Mathur and Yang 2015; Nisenbaum et al. 2021).

Usher syndrome is heterogeneous, both clinically and genetically, and has been classified into three distinct clinical subtypes—USH1, USH2, and USH3—based on symptom severity, progression, and age at onset. These three clinical subtypes are associated with nine causal genes encoding various proteins expressed in the inner ear and retina and playing key roles in auditory sensory cell development and function, and photoreceptor maintenance. However, a growing list of additional genes have been reported to be associated with a poorly defined clinical subtype called “atypical Usher syndrome” that does not meet the canonical criteria for the three recognized Usher syndrome subtypes (Bolz 2020; Castiglione and Moller 2022; Fuster-Garcia et al. 2019; Nisenbaum et al. 2021; Nolen et al. 2020; Stiff et al. 2020). Moreover, for each Usher syndrome-associated gene,

Sedigheh Delmaghani and Aziz El-Amraoui are Joint senior.

<figure><img src="image_2.png" /></figure>

Sedigheh Delmaghani
sedigheh.delmaghani@pasteur.fr

<figure><img src="image_3.png" /></figure>

Aziz El-Amraoui
aziz.el-amraoui@pasteur.fr

<footnote n="1">¹ Institut Pasteur, Institut de l'Audition, Université Paris Cité, INSERM UMRS1120, Progressive Sensory Disorders, Pathophysiology and Therapy Unit, F-75012 Paris, France</footnote>
clinical features can vary according to the type and location of the causal gene, making it difficult to achieve an accurate diagnosis and classification of Usher syndrome (Bolz 2020; Castiglione and Moller 2022; Fuster-Garcia et al. 2019; Nisenbaum et al. 2021; Nolen et al. 2020; Stiff et al. 2020). The early and accurate diagnosis of Usher syndrome is essential for effective clinical management of the patient, and to improve our understanding of genotype–phenotype relationships in USH, in anticipation of treatment options, including cochlear implantation. Here, we summarize key information about the clinical and genetic aspects of Usher syndrome. The list of genes associated with Usher syndrome has grown in recent years. We therefore revisit this list, considering the available information about the classic Usher genes and the atypical and ultra-rare Usher-like forms, and the function of the corresponding proteins in the inner ear and eye. The redefinition of criteria for Usher syndrome is important for clinicians, scientists, and patients; it will improve patient screening and counseling, and accurately guide the development of precision medicine-based therapies.

## Anatomy and function of the inner ear and eye, the sensory organs targeted by Usher syndrome

The main target organs of Usher syndrome are the inner ear and eye. The extent of the sensory deficit in these two sensory organs determines the severity of clinical symptoms, according to the form of Usher syndrome. Below, we provide general information about the anatomy of these organs, focusing on key Usher target cells.

## The inner ear, and the sensory hair cells

The inner ear houses the sensory organ for balance, the vestibule, and the organ responsible for hearing, the cochlea (Fig. 1A, B) (Delmaghani and El-Amraoui 2020). Balance and hearing depend on the process of mechanoelectrical transduction, which occurs in highly specialized polarized epithelial cells called hair cells: type I and type II hair cells in the vestibule (vestibular hair cells or VHCs) (Fig. 1C), and the inner (IHC) and outer (OHC) hair cells in the cochlea (Fig. 1D). The mechanosensitive organelle in all hair cells is the hair bundle (Delmaghani and El-Amraoui 2020). It consists of 50–100 F-actin-filled stereocilia that project a few micrometers above the apical cell surface, forming a staircase pattern increasing towards a single transient genuine cilium, the kinocilium (which is only transient during the development of cochlear sensory cells) (Fig. 1C, D) (Delmaghani and El-Amraoui 2020).

The basic principles of hair-bundle function are similar between the vestibule and cochlea, but hair-bundle organization, geometry, physical and functional properties vary according to the position of the hair cell in the corresponding sensory organ. Vestibular hair bundles are often compact, with a staircase composed of four to five rows of stereocilia. In the cochlea, the OHC hair bundles are arranged in three rows, forming a distinct "V"-shaped (or W-shaped) staircase, whereas the IHC hair bundles have a flatter, slightly curved profile, forming a U-shape (Fig. 1C, D). The cochlear hair bundles are extremely sensitive; they convert nanometer displacements of the stereocilia induced by sound waves into changes in membrane potential. In the IHCs, this results in neurotransmitter release, and signal transmission to the brain (Fig. 1; see (Delmaghani and El-Amraoui 2020)).

## The retina, and the sensory photoreceptor cells

In the eye, light must pass through several structures and compartments—the cornea, lens, vitreous, and retinal cell layers—before it reaches the photoreceptor cells (rods and cones) (Botto et al. 2021; Crane et al. 2021). The visual signal is initiated by the photosensitive opsins, which trigger a phototransduction cascade in the outer segment (the site of phototransduction) of the photoreceptor cells (Fig. 2A, B). The outer segment contains hundreds of membrane disks stacked into an ordered array, organized around a microtubule-based axoneme that begins in the distal portion of the inner segment and passes through the connecting cilium extending along the edge of the outer segment base (Fig. 2B1) (Botto et al. 2021; Crane et al. 2021).

One key property of the photoreceptor cells is the daily renewal of the membranous disks in the photosensitive outer segment (Young 1967, 1974). The new disks (~10% are turned over each day) form at the base of the outer segment, and the old disks are taken up into the retinal pigment epithelium cells surrounding the distal tip of the outer segments by phagocytosis (Young 1974). This daily turnover of the outer segment disks is sustained by the continual generation of phototransduction proteins in the (metabolic) inner segment and their delivery to the OS via the connecting cilium. Every minute, ~2000 molecules of opsin, the predominant protein in the disks, pass through the connecting cilium (Besharse and Wetzel 1995; Young 1967); Fig. 3B2). There may be differences between species in terms of the cellular architecture and distribution in the retina of the light-sensitive photoreceptor cells, the rods and cones. For example, the fovea, which underlies high-acuity diurnal vision thanks to its enrichment in cones, is absent from the rodent retina. Furthermore, in some species (e.g., amphibians, non-human primates,
<figure><img src="image_4.png" /><figcaption>**Fig. 1** Anatomy of the mammalian ear, and the balance and hearing sensory organs in the inner ear. **A** The mammalian ear consists of 3 compartments: the outer, middle and inner ear. **B** The inner ear contains the vestibule (balance organ), and the cochlea (hearing organ). **C, D** The vestibular (C) and auditory (D) sensory epithelia are composed of the hair cells, associated innervation, and various types of supporting cells. In the vestibule, type I and type II vestibular hair cells (VHCs) sense head and body motion. In the cochlea, hearing results from the processing of sound waves by the hair cells, which are of two types: the inner hair cells (IHCs), which are the genuine</figcaption></figure>

auditory sensory cells responsible for signaling to the brain, and the outer hair cells (OHCs), which act as mechanical amplifiers, conferring on the mammalian cochlea its high sensitivity, and frequency discrimination capacity (low frequencies at the apex (20 Hz)-high frequencies at the base (20 kHz) in humans). The scanning electron micrographs illustrate the staircase pattern of the highly organized hair bundles, arranged in different shapes in different types of hair cell (C, D). In mammals, only the vestibular hair bundle retains the kinocilium (artificially colored in green in C), a true cilium that stands at the tallest edge of the hair bundle. Scale bar = 1 µm

and humans, microvillus-like structures called calyceal processes emerge at the tip of the inner segment and surround the base of the outer segments (see (Sahly et al. 2012); Fig. 3B2). However, the presence of two to three apical processes/membrane projections extending along the edge of the outer segment, as observed in mice, does not meet the definition for calyceal processes. Calyceal processes were first described 50 years ago (Brown et al. 1963; Cohen 1963; Ulshafer et al. 1987). They are specialized membrane processes satisfying the following three criteria: (i) they must contain a sufficiently large number of apical processes, generally 8 to 16; (ii) organized in a ring pattern, and forming a calyx around the outer segment, and (iii) labeled by F-actin staining, demonstrating their microvillus-like nature due to the presence of a core of actin filaments (Fig. 3B).

## The classification of Usher syndrome: three typical Usher clinical forms

### Clinical features

Usher syndrome is clinically heterogeneous and characterized by a combination of sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP), with variable vestibular dysfunction. It is traditionally classified into three different subtypes—USH1, USH2, and USH3—depending on age at onset, severity and progression, and the presence or absence of vestibular dysfunction (Hope et al. 1997; Kimberling et al. 2010; Nisenbaum et al. 2021; Toms et al. 2020b) (see Fig. 3A–C).
<figure><img src="image_5.png" /><figcaption>**Fig. 2** Anatomy of the eye, the retinal layers and the light-sensitive rod and cone photoreceptor cells. **A** The retina is a neural layer lining the back of the eye and containing retinal pigment epithelium cells (RPE) together with rod and cone photoreceptor cells. The photoreceptors are connected to various horizontal cells, bipolar cells, amacrine cells and ganglion cells present in the inner retina. Müller cells are glial cells that span all cell layers of the retina. **B** Schematic diagram illustrating the apical region of the photoreceptor cells. **B1.** Despite differences in their morphological architecture, the rod and cone photoreceptor cells have the same apical organization: a connecting cilium with an axoneme connects the light-sensitive outer</figcaption></figure>

segment consisting of tightly packed membrane disks with the inner segment containing all the organelles required for energy and protein synthesis. The connecting cilium and the periciliary ridge region form the periciliary membrane complex. **B2.** In some species (e.g., amphibians, non-human primates and primates), microvillus-like structures emerge from the top of the inner segment and form a collar around the base of the photoreceptor outer segment. These finger-like structures, visible on the scanning electron micrograph, are known as calyceal processes. Scale bar = 1 µm. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; OPL, outer plexiform layer; and INL, inner plexiform layer

Usher type 1 (USH1) is the most severe form, accounting for about 25–44% of all cases of Usher syndrome (Bonnet et al. 2016; Fuster-Garcia et al. 2021; Jouret et al. 2019; Toms et al. 2020b). It is characterized by severe-to-profound congenital SNHL, vestibular areflexia, and a prepubertal onset of retinitis pigmentosa (RP) (Kremer et al. 2006; Mathur and Yang 2015; Geleoc and El-Amraoui 2020) (Fig. 3A). Many USH1 patients do not begin to walk before the age of 18 months, and vestibular areflexia is responsible for the delayed motor development observed in these patients (Loundon et al. 2003). The patients compensate for their vestibular areflexia through vision until the onset of RP, although they often present difficulties performing activities that require balance (Loundon et al. 2003). USH1 retinopathy is classified as a rod-cone dystrophy, with rod abnormalities appearing first and rapidly worsening, followed by slowly progressing cone dysfunction, and photoreceptor cell degeneration (Jacobson et al. 2008, 2011; Khateb et al. 2019). Night blindness is the first symptom of RP and may be followed by a narrowing of the field of vision (“tunnel vision”), which rapidly progresses to complete blindness by the age of 30 years

(Jacobson et al. 2008) (Jacobson et al. 2011; Khateb et al. 2019).

Usher type 2 (USH2) is the most common form of USH, accounting for more than half of all cases (Bonnet et al. 2016; Jouret et al. 2019; Toms et al. 2020b; Fuster-Garcia et al. 2021). USH2 patients typically have a sloping audiogram, mild-to-moderate congenital SNHL for low frequencies and severe-to-profound SNHL for higher frequencies (Abadie et al. 2012) (Fig. 3B). Speech is not usually affected, and vestibular function is normal. Symptoms of rod-cone dystrophy manifest later in USH2 patients than in USH1 patients, as retinitis pigmentosa is not usually diagnosed until the second decade of life, or later (Van Aarem et al. 1995; Millan et al. 2011; Pierrache et al. 2016; Toms et al. 2020a).

Usher type 3 (USH3) is the least common type of USH, accounting for 2–4% of all cases, but with a high prevalence in Finnish and Ashkenazi Jewish populations, probably due to founder effects (Adato et al. 2002; Ben-Yosef and Friedman 2003; Malm et al. 2011; Millan et al. 2011; Ness et al. 2003; Marouf et al. 2022). The audiovestibular features of USH3 are the most variable among Usher subtypes (Khan
<table><thead><tr><th>A</th><th>Usher syndrome type I (USH1)</th></tr></thead><tbody><tr><td>Congenital, profound hearing loss</td><td>Bilateral vestibular areflexia</td><td>Pre-pubertal onset of retinitis pigmentosa</td></tr></tbody></table>

**USH1B:** myosin VIIa, an actin-based motor protein

MYO7A: 11q13.5, 6645 bp (OMIM 276903); 2 isoforms (N1 and N2)

**USH1C:** harmonin, a PDZ domain containing scaffold protein
  class b isoform

USH1C: 11p15.1 (OMIM 605242); 3 isoforms, a, b and c

**USH1D:** cadherin-23, a cadherin-related protein

CDH23: 10q22.1 (OMIM 605516)

**USH1F:** protocadherin-15, a cadherin-related protein
  CD2 isoform

PCDH15: 10q21.1 (OMIM 605514), distinct isoforms, with multiple EC repeats, or different cytos Domains (CD1, CD2, or CD3)

**USH1G:** Sans, a scaffold protein

USH1G, 17q25.1 - OMIM 607696

<table><thead><tr><th>C</th><th>Usher syndrome type III (USH3)</th></tr></thead><tbody><tr><td>Postlingual, progressive hearing loss</td><td>Variable vestibular function</td><td>Variable onset, and severity of retinitis pigmentosa</td></tr></tbody></table>

<table><thead><tr><th>D</th><th>The Usher protein network</th></tr></thead><tbody><tr><td>USH1</td><td>MYO7A</td><td>USH2</td><td>USH3</td><td>Other</td></tr></tbody></table>

<table><thead><tr><th>B</th><th>Usher syndrome type II (USH2)</th></tr></thead><tbody><tr><td>Congenital, moderate-to-severe hearing loss</td><td>Normal vestibular function</td><td>Post-pubertal onset of retinitis pigmentosa</td></tr></tbody></table>

**USH2A:** usherin (the long transmembrane isoform)

USH2A: 1q41 (OMIM 608400), secreted & transmembrane isoforms

**USH2C:** ADGVR1, seven-pass transmembrane protein (adhesion G-protein coupled receptor V1)

ADGVR1 5q14.3 (OMIM 602851)

**USH2D:** whirlin, PDZ domain-containing scaffold protein

Long isoform (L)

WHRN: 9q32 (OMIM 607928), short & long isoforms

**USH3A:** clarin-1, tetraspanin-like glycoprotein

CLRN1: 3q25.1 (OMIM 606397)

<figure><img src="image_6.png" /></figure>

**Fig. 3** Illustration of the differences between the three clinical forms of Usher syndrome and the Usher proteins. Usher syndrome (USH) is classified into three types—USH1 (A), USH2 (B) and USH3 (C)—on the basis of age at onset and severity of hearing loss, the presence or absence of vestibular deficits, and age at onset of retinitis pigmentosa. Based on genetic evidence and the functions of Usher proteins and phenotypic manifestations in disease models, there is good evidence for nine undisputed Usher syndrome genes: Five USH1 genes A MYO7A (myosin VIIa, responsible for USH1B), USH1C (harmonin, responsible for USH1C), CDH23 (cadherin-23, responsible for USH1D), PCDH15 (protocadherin-15, responsible for USH1F); three USH2 genes B USH2A (usherin, responsible for USH2A), ADGRV1 (ADGRV1, adhesion G protein-coupled receptor V1, responsible for

USH2C), WHRN (whirlin, responsible for USH2D), and one USH3 gene C CLRNI (clarin-1, responsible for USH3A). For more details on any USH gene, please refer to the references for the corresponding OMIM number, and <http://hereditaryhearingloss.org>. D The Usher network analysis using Cytoscape software. Among USH1 interactions, almost all interactions (5/7) were identified at least once using detection methods indicative of direct physical contact between proteins (purple edges). The blue, and green lines indicate the existence of experimental evidence for the involvement of these proteins in one 'physical association' or more 'association' complexes, respectively. Among the other proteins referred to as USH molecules (yellow boxes), several has no connection to the classic USH proteins
et al. 2017; Ness et al. 2003). USH3 patients display progressive, post-lingual SNHL, beginning at higher frequencies, mostly during childhood, although onset may occur as late as the age of 35 years (Ness et al. 2003) (Fig. 3C). Progression is variable but, in most cases, the patients ultimately become profoundly deaf (Adato et al. 2002; Khan et al. 2017; Ness et al. 2003). USH3 patients have well-developed speech. Vestibular dysfunction is variable and occurs in about half the patients (Adato et al. 2002; Ben-Yosef and Friedman 2003; Malm et al. 2011; Millan et al. 2011; Ness et al. 2003). Retinitis pigmentosa also has a variable onset, but is post-pubertal, generally occurring after the age of 20 years (Herrera et al. 2008; Malm et al. 2011).

## The genetic landscape of the Usher syndrome

In addition to its clinical heterogeneity, Usher syndrome is also genetically heterogeneous. Nine genes have been clearly identified as responsible for the three subtypes of Usher syndrome (Fig. 3A–C). USH1 is caused by pathogenic variants of the following five genes: *MYO7A* (myosin VIIA; USH1B) (Weil et al. 1995), *USH1C* (harmonin; USH1C) (Verpy et al. 2000), *CDH23* (cadherin 23; USH1D) (Bork et al. 2001) (Bolz et al. 2001), *PCDH15* (protocadherin 15; USH1F) (Ahmed et al. 2001), and *USH1G* (sans; USH1G) (Weil et al. 2003) (Fig. 3A). USH2 is caused by pathogenic variants of the following three genes: *USH2A* (usherin; USH2A) (van Wijk et al. 2004; Weston et al. 2000), *ADGRV1* (adhesion G protein-coupled receptor V1; USH2C) (Weston et al. 2004), and *WHRN* (whirlin; USH2D) (Ebermann et al. 2007) (Fig. 3B). *CLRN1* (clarin 1; USH3A) is the only gene shown to be associated with USH3 (Adato et al. 2002; Fields et al. 2002) (Fig. 3C).

These USH genes encode proteins from different classes and families with different functions, including motor proteins, scaffold proteins, transmembrane proteins, adhesion proteins, and G protein-coupled receptors (Fig. 3). USH proteins are organized into a protein “interactome” in both the inner ear and the retina, where the Usher molecular complexes have been shown to be crucial for the development and function of the auditory sensory cells and for the maintenance of retinal photoreceptor cells (El-Amraoui and Petit 2005, 2014; Kremer et al. 2006; Maerker et al. 2008; Bonnet and El-Amraoui 2012; Mathur and Yang 2015; Geleoc and El-Amraoui 2020).

## Function of Usher proteins in health and disease

The precise sequence of pathogenic events leading to sensory loss (hearing, balance, and vision) in Usher syndrome remains unclear. However, based on the known properties of

Usher proteins and elucidation of the molecular complexes they form, steady progress has been made over the years towards understanding how each Usher protein cooperates in well-defined and orchestrated pathways in the inner ear and retinal Usher target cells. Multiple protein–protein interactions have been identified between USH proteins (Adato et al. 2005b; El-Amraoui and Petit 2005, 2014; Kremer et al. 2006; Maerker et al. 2008; Mathur and Yang 2015; Geleoc and El-Amraoui 2020) (see Fig. 3D). Through search of the literature and protein–protein interaction databases, we used Cytoscape (Shannon et al. 2003), considering the IMEx curation rules (Orchard et al. 2012) to reconstitute the Usher network. This reveals that the nine Usher proteins are linked to a total of 20 interactions reported for mouse and human orthologous proteins (see Fig. 3D). The number of connections varies greatly between the 9 Usher proteins (colored boxes), from 1 (CLRN1) to 7 (MYO7A and USH1C), with an average of 4 neighbors per protein (Fig. 3D). Extensive studies of the animal models available for each form of Usher syndrome (reviewed in El-Amraoui and Petit 2005, 2014; Reiners et al. 2006; Kremer et al. 2006; Maerker et al. 2008; Mathur and Yang 2015; Geleoc and El-Amraoui 2020), have shed light on how the lack of a given USH protein can affect the subcellular distribution of at least one other USH protein in hair cells and/or photoreceptor cells, further confirming in vivo the interdependence of USH proteins for normal function (Boeda et al. 2002; Senften et al. 2006; Lefevre et al. 2008). All the available data suggest that the hair cells and photoreceptor cells, which have structural and functional characteristics in common, are the key primary targets of Usher sensory deficits (El-Amraoui and Petit 2005, 2014; Kremer et al. 2006; Reiners et al. 2006; Maerker et al. 2008; Cosgrove and Zalocchi 2014; Mathur and Yang 2015; Geleoc and El-Amraoui 2020). Detailed information about the complete spatiotemporal expression profiles (e.g., in synaptic regions, adherens junctions) of USH proteins in hair cells and photoreceptors, and the additional roles of these proteins in other cells in the retina (e.g., Müller cells, amacrine cells, and RPE cells), the brain and beyond is provided by other recent reviews (Reiners et al. 2006; Maerker et al. 2008; Gregory et al. 2011; El-Amraoui and Petit 2014; Mathur and Yang 2015). We will focus here on holistic molecular working models illustrating, for each form of Usher syndrome, the key contributions of the complexes to the development, differentiation, and functioning of the hair bundle (Fig. 4), and at the interface between the inner and outer segments of photoreceptor cells (Fig. 5).

<figure><img src="image_7.png" /></figure>
<figure><img src="image_8.png" /><figcaption>**Fig. 4** Usher proteins in the hair bundle and the principal related pathogenic phenotypic features in the inner ear. A Developing and mature stages of the cochlear hair bundle illustrating the dynamic changes in the various types of hair-bundle link: the transient apical lateral links, ankle links, and kinocilial links disappear after bundle maturation, by P12, in mice. The top connectors develop late in differentiation and persist in the mature hair bundles. The tip link is a unique fibrous link that connects the tip of a stereocilium to the side of the adjacent stereocilium. It is present in both developing and mature hair bundles. In mammals, the kinocilium, with its 9+2 axoneme pattern and typical motile cilium structure, is absent from mature hair bundles. The middle close-up views illustrate the func-</figcaption></figure>

tion of USH proteins in the hair bundle. Cadherin 23 homodimers and protocadherin 15 homodimers interact to form the tip links, with protocadherin 15 forming the lower component that gates the MET channels. Myosin VIIa, harmonin, and sans cross-link the stereociliary membrane to the core of actin filaments. USH2 proteins are the key components of the ankle links, which eventually disappear and are absent from mature auditory hair bundles. It remains unclear whether USH3A acts as an accessory protein of the MET channel complex. B Usher protein defects cause a wide range of physiological, morphological, and molecular abnormalities; the main phenotypic findings for USH1 are listed. The USH3 SEM micrograph is adapted from (Dulon et al. 2018). Scale bar = 1 µm

## USH proteins during morphogenesis of the mechanosensitive hair bundles

Fortunately, mouse inner ears and their specialized mechanosensitive hair cells work much like those of humans (Bowl and Dawson 2015). This has made it possible to make steady progress towards understanding the precise mechanisms underlying the hearing and balance deficits of Usher syndrome (Delmaghani and El-Amraoui 2020). An abnormal shape and dysfunction of the hair bundles is common to all Ush mutant mice, with severity depending on the type of hair cell and genetic type of USH (El-Amraoui and Petit 2005; Petit and Richardson 2009; Bonnet and El-Amraoui 2012; Mathur and Yang 2015; Geleoc and El-Amraoui 2020). During morphogenesis and in the mature hair bundles, the stereocilia and kinocilium (when present) are interconnected by several morphologically and molecularly different fibrous links (Goodyear et al. 2005). In all hair bundles, a single obliquely inclined tip-link (TL) connects the tip of the distal stereocilium to the shaft of the adjacent taller stereocilium (Kachar et al. 2000). Transient links are prominent

in developing hair bundles: the transient lateral links (tLL, at the apex of stereocilia), ankle links (AL, located in or just above the tapered region at the base of each stereocilium), and kinocilial links (KL; connecting the kinocilium to the adjacent stereocilia) (Goodyear et al. 2005). Only the tip links and the top connectors just below them persist in mature adult hair bundles (Fig. 4A) (Goodyear et al. 2005). Collectively, protein–protein interaction studies and the characterization of animal models of Usher syndrome have led to the establishment of models explaining the hearing and balance dysfunctions in this syndrome (Bonnet and El-Amraoui 2012; El-Amraoui and Petit 2005; Geleoc and El-Amraoui 2020; Mathur and Yang 2015; Michalski and Petit 2019). For USH1, myosin VIIa and sans are required, in early differentiating hair cells, for the transfer of most USH1 and USH2 proteins from the apical surface of the hair cell to the stereocilia, where they become restricted to the tip region. Once in the stereocilia, cadherin-23 and protocadherin-15 heterodimers form the transient fibrous apical links connecting the stereocilia to each other and to the kinocilium (see Fig. 4A) (Boeda et al. 2002; Siemens et al.
<figure><img src="image_9.png" /><figcaption>**Fig. 5** Usher proteins in photoreceptor cells and the principal related pathogenic phenotypic features in the retina. **A** The functional assemblies of Usher proteins operating in the hair bundle also play analogous roles in the photoreceptor cells, notably in the periciliary ridge membrane complex (PMC) and the calyceal processes (when present). Based on their presence close to the vesicle loading point at the base of the PMC region, the USH2 proteins (along with myosin VIIa and sans) were thought to play a role in vesicle transport between the inner and outer segments of the photoreceptors. Recent evidence suggests that USH1 proteins play a key role at the interface between the inner and outer segments, probably controlling the size</figcaption></figure>

of newly produced membrane disks and contributing to their correct organization in the apical zone of the PMC region. **B** As in the inner ear, USH protein defects cause diverse phenotypic abnormalities in the retina, including decreased electroretinogram responses (ERGs), probably due to misshapen photoreceptor disks (as shown in *Xenopus* morphants, adapted from Schietroma et al. (2017)). Other abnormalities—opsin transport delay and melanosome mispositioning—are observed in absence of Myo7a. The precise distribution of clarin-1 in the retina is currently unknown, and there are no mouse USH3A models for the retinal phenotype, limiting the accuracy of extrapolations of USH3 function in the eye. Scale bar = 1 µm

2002). The other three USH1 proteins—harmonin, sans and myosin VIIa—anchor these links to the actin filaments of the stereocilia, probably mediating the tension applied to the early embryonic lateral links anchored to actin filaments and ensuring the cohesion and correct orientation of the hair bundle Fig. 4) (Boeda et al. 2002; Siemens et al. 2002; Lefevre et al. 2008; Michalski et al. 2009; Grillet et al. 2009; Bahloul et al. 2010).

For USH2, the three UHS2 proteins—usherin, ADGVR1 and whirlin—are transiently colocalized at the base of the stereocilia, where they are thought to be components of the ankle-link molecular complex (Adato et al. 2005a; McGee et al. 2006; Michalski et al. 2007; Yagi et al. 2007)}. Myosin VIIa and PDZD7, expressed at the base of the stereocilia, are also components of this complex (Zou et al. 2014). A lack of USH2 proteins affects the formation of ankle links (McGee et al. 2006; Michalski et al. 2007; Yagi et al. 2007). These links are transient, remaining present during development almost up

to the final maturation of the hair bundle (Goodyear et al. 2005). Their absence leads to misshaped OHC bundles (McGee et al. 2006) (Michalski et al. 2007; Yagi et al. 2007), more prominently at the base of the cochlea and probably accounting for the severity of hearing loss for high-frequency sounds in USH2 patients. USH1 proteins are produced and normally targeted to the hair bundle in Usher 2 mouse models. This normal presence of USH1 proteins accounts for the cohesive coupling of the stereocilia being maintained during hair-bundle morphogenesis. Conversely, the compact hair bundles of vestibular hair cells may be able to cope with the minimal misshaping caused by the loss of USH2 proteins, accounting for the normal vestibular function in USH2 patients.

For USH3A, a misalignment of the hair bundles, with occasional bundle fragmentation, has been observed in the absence of clarin-1 (Geng et al. 2009; Dulon et al. 2018) but it remains unclear how the absence of clarin-1 leads to such disorganization.

<figure><img src="image_10.png" /></figure>
## USH1 and USH3A proteins at the core of the mechanoelectrical transduction machinery

Studies of conditional mutant mice in which USH proteins are inactivated only at postnatal stages have shown that the USH1 and USH3 proteins also play crucial roles in the mature adult hair bundle (Fig. 4). Several studies have shown that, in mutant mice, mechanoelectrical transduction (MET) is altered in the absence of a particular USH1 protein or USH3A, demonstrating an essential role for these proteins in the MET machinery. Cadherin-23 and protocadherin-15 not only contribute to the early transient lateral links, but they also form the upper and the lower tip-link, respectively. This link is thought to gate the mechanoelectrical transduction channels (see Fig. 3). It has been suggested that myosin VIIa, sans and harmonin form the core of the upper tip-link density complex, a multiprotein platform ensuring dynamic crosslinking of the tip-link to the actin filaments of the stereocilia (Caberlotto et al. 2011; Grati and Kachar 2011; Grillet et al. 2009; Michalski et al. 2007). It remains unclear how the absence of clarin-1 disrupts MET currents, and whether this tetraspanin-like glycoprotein acts as an accessory protein of the MET channel complex. One structural phenotype common to all USH1 and USH3A mutant mice is a progressive regression of the mechanotransducing stereocilia (short and middle rows of stereocilia). This observation highlights the positive role of the intact mechanoelectrical transduction machinery and F-actin polymerization in maintaining the correct length of the stereocilia (Caberlotto et al. 2011), as supported by experimental, mechanical and functional investigations (Velez-Ortega et al. 2017).

## USH proteins have key functions at the interface between the inner and outer segments of photoreceptor cells

Age at onset, progression and severity differ between the various forms, but all USH patients ultimately develop retinitis pigmentosa, leading to blindness (El-Amraoui and Petit 2014; Kremer et al. 2006; Mathur and Yang 2015; Geleoc and El-Amraoui 2020; Toms et al. 2020b; Nisenbaum et al. 2021; Castiglione and Moller 2022). By contrast, despite the occurrence of quantifiable structural and functional retinal abnormalities in many Ush mice, only a few USH2 models develop unambiguous retinal cell degeneration and vision defects (Yang et al. 2010). The discrepancy between the mouse and human retinal phenotypes has made it particularly difficult to unravel the

precise mechanism of Usher vision loss. Possible explanations for this phenotypic discrepancy include the shorter lifespan of the mouse, differences in light exposure (diurnal versus nocturnal species), the functional redundancy of USH proteins in the retina, and intrinsic structural differences in photoreceptor cell architecture (El-Amraoui and Petit 2005). One key structural difference between species is the presence or absence of well-developed calyceal processes in the retina (Sahly et al. 2012). These microvillus-like structures are present in the photoreceptors of humans, macaques, and frogs, but not in those of mice or other rodents (Sahly et al. 2012). The generation and characterization of novel animal models better mimicking human ocular USH disease have proved crucial for gaining insight into the molecular mechanisms underlying retinal dysfunction and degeneration in USH (Dinculescu et al. 2021; Mathur and Yang 2015, 2019; Williams 2002). As for the USH1 complex in hair bundles, there is increasing evidence for a holistic molecular mechanism involving the five USH1 proteins (myosin VIIa, harmonin, cadherin-23, protocadherin-15 and sans) acting together in photoreceptor cells (Sahly et al. 2012). Studies in amphibian (Schietroma et al. 2017) and zebrafish (Miles et al. 2021) models have suggested that a defect of the USH1 protein network between the photoreceptor outer segment and the calyceal processes is probably the cause of USH1 retinal dystrophy in humans (see Fig. 5). Interestingly, a pig model of USH1C lacking harmonin, *USH1C<sup>R31X</sup>*<sup>+</sup>, was recently reported to mimic the human disease, displaying combined deafness, changes in photoreceptor architecture, and significantly impaired visual function (Grotz et al. 2021).

The use of sophisticated experimental protocols in USH mutant mice, some of which display a late-onset progressive decrease in electroretinogram (ERG) responses, has facilitated the identification of some of the retinal functions of Usher proteins under normal conditions and in response to challenges, such as light–dark adaptation (Lopes et al. 2011; Peng et al. 2011; Sethna et al. 2021b; Tian et al. 2016), and light exposure in albino versus pigmented genetic backgrounds (Trouillet et al. 2018). A role for myosin VIIa (Peng et al. 2011) and protocadherin-15 (Sethna et al. 2021b) in the light-induced translocation of arrestin and transducin between the inner and outer segments has been described, indicating that protocadherin-15 is essential for the rapid shuttling of proteins between photoreceptor segments. Myosin VIIa has also been implicated in opsin transport in photoreceptor-connecting cilia and the correct positioning of melanosomes in RPE cells (Liu et al. 1998a). The opsin delay in the connecting cilium (Liu et al. 1997a, 1999a), and the aberrant positioning of melanosomes and phagosomes in RPE cells observed in Myo7a-deficient mice (El-Amraoui et al. 2002; Gibbs et al. 2004; Liu et al. 1998a) also support
a role for this motor protein as a cargo transporter in these
cells.

For USH2, there is compelling evidence to suggest that the USH2 proteins usherin, ADGVR1, and whirlin are present in the photoreceptor periciliary ridge membrane complex (PMC) in mouse (Maerker et al. 2008; Yang et al. 2010; Zou et al. 2011), zebrafish (Dona et al. 2018) and macaque (Sahly et al. 2012) models. The PMC region is located in a spatially restricted inner segment membrane region surrounding the photoreceptor-connecting cilium (Peters et al. 1983; Watanabe et al. 1999). Like a pericuticular necklace in hair cells or a peri-terminal web region in epithelial cells, this compartment probably functions as a “hub” diffusion barrier, controlling transport to the overlying modified apical sensory cilia: the sound/motion-receptive hair bundle (Fig. 4) or the light-sensitive outer segment (Fig. 5). USH2 proteins are thought to provide structural support to the PMC region, with usherin and ADGVR1 forming fibrous links coupling the PMC to the connecting cilium (El-Amraoui and Petit 2014; Maerker et al. 2008; Mathur and Yang 2015). They are also involved in vesicle docking with the plasma membrane during protein translocation to the outer segment (Maerker et al. 2008; Toualbi et al. 2020; Zou et al. 2011).

Interestingly, a recent high-resolution imaging study with cilium- and Usher protein-specific photoreceptor markers also revealed planar polarity of the cone photoreceptors in the primate retina (Verschueren et al. 2021). The cone photoreceptors were shown to display planar polarity organized radially around the optical center of the eye, which is probably important for well-known mechanisms, such as the Stiles Crawford effect thought to align cone photoreceptors with the pupil axis through a mechanotransduction mechanism very similar to that of auditory cells (Verschueren et al. 2021). By coupling the inner segment periciliary membrane to both the cilium and the base of the outer segment (coupled to the calyceal processes in some species), the USH1 and USH2 proteins provide a dynamic and continuous cytoskeleton-based mechanical structure that is essential for the architectural integrity and function of photoreceptor cells (Sahly et al. 2012; Schietroma et al. 2017; Verschueren et al. 2021) (Fig. 5A). Further studies are required to determine the nature and extent of mechanotransduction processes within the retina (Cadoni et al. 2021), and to determine whether and how Usher proteins are involved in this process.

For USH3, no overt retinal defect was observed in *Clrn1*-deficient mice (Dulon et al. 2018; Tian et al. 2016). Potentially low levels of *CLRN1* expression in the photoreceptor cells cannot be excluded, but there is evidence for high transcript levels in the retinal inner nuclear layer of mice, pig and humans (Cosgrove and Zallocchi 2014; Dinculescu et al. 2021). The establishment of new models in non-rodent species could help to determine the key role of clarin-1 in the retina.

Current progress in therapeutic studies
on Usher syndrome

In the last decade, efficacy has been demonstrated in pre-
clinical studies for diverse therapeutic strategies, several
of which have entered clinical trials aiming to improve
vision in Usher-related RP and other inherited retinal dys-
trophies (Botto et al. 2021; Crane et al. 2021; Sahel et al.
2019; Geleoc 2020; Toms et al. 2020b). These strategies
include gene replacement, gene editing, nonsense suppres-
sion and antisense oligonucleotides (ASOs) (Botto et al.
2021; Crane et al. 2021; Sahel et al. 2019; Geleoc 2020;
Toms et al. 2020b). The first studies of gene replacement
therapy with a commercial adeno-associated virus (AAV)
were performed on the retinas of patients with an autoso-
mal recessive form of Leber congenital amaurosis; these
patients develop severe retinal dystrophy due to biallelic
mutations of *RPE65* (Maguire et al. 2019; Russell et al.
2017). Several clinical trials have been set up for treat-
ments aiming to prolong retinal cell survival and halt
vision loss in USH1 and USH2 patients. The first Usher
gene therapy in humans tested in a phase I/II clinical
trial involved the equine infectious anemia virus (EIAV)
lentiviral-based subretinal delivery of *MYO7A* in USH1B
patients (Sanofi SAR421869; Trial #NTC01505062).
Another USH1B trial, also in phase I/II, is underway,
for full-length myosin VIIa supplementation with a dual
vector system in the retina in USH1B patients (UshTher,
Horizon, 2020; Trial #NCT02065011). USH2 patients
have been included in a trial of subretinal capsules of
human NT-501 cells delivering ciliary neurotrophic factor
(CNTF). This factor prolongs the survival of photorecep-
tor cells, especially cones, and halts vision loss (Trials
#NCT00447980; #NCT01530659). In another phase I/
II clinical trial (ProQR, Stellar; Trial #NCT03780257),
USH2A patients were treated by intravitreal injection of
an antisense oligonucleotide (ASO), QR-421a, designed
to abolish the in-frame deletion of exon 13 of the *USH2A*
gene, one of the commonest pathogenic variants of this
gene in humans (Dulla et al. 2021). QR-421a has been
shown to be effective in a zebrafish *Ush2a* model (Dona
et al. 2018; Han et al. 2018). ASO-based targeted therapies
have also been successfully used to correct a highly preva-
lent *USH1C* mutation, leading to significant improvements
in hearing and balance functions in *USH1C* knock-in mice
(Lentz et al. 2013, 2020).

Other approaches targeting specific Usher gene muta-
tions include translational readthrough-inducing drugs
(TRIDs), a new generation of aminoglycosides targeting
nonsense mutations. These drugs have been assessed in
the retina of *Ush1c* mice (carrying p.(Arg31*)), in which
they induced harmonin expression (Goldmann et al. 2012;
Nagel-Wolfrum et al. 2016). Gene editing with zinc finger
nucleases and the CRISPR/Cas9 system has also been used
for successful in vitro repair in stable *Ush1C* mouse cell
lines carrying p.(Arg31*) and in human *USH2A* fibroblasts
and induced pluripotent stem cells harboring c.2299delG
p.(Glu767Serfs*21), a common *USH2A* mutation, respec-
tively (Fuster-Garcia et al. 2017; Overlack et al. 2012) (see
recent reviews Geleoc and El-Amraoui 2020; Toms et al.
2020b; Williams et al. 2017).

Patients with Usher syndrome may benefit from the fit-
ting of hearing aids or cochlear implants, which can par-
tially alleviate auditory sensory deprivation (for review
see Davies et al. 2021). Gene replacement with AAVs of
various serotypes has been successfully used to replace
four Usher genes in mouse models; *USH1C* (Landegger
et al. 2017; Pan et al. 2017), *USH1G* (Emptoz et al. 2017),
*USH2D* (Chien et al. 2016; Isgrig et al. 2017) and *USH3A*
(Dulon et al. 2018; Geng et al. 2017; Gyorgy et al. 2019).
In these studies, the efficacy of hearing recovery depended
on the type of USH gene, but an almost full recovery of
vestibular function was obtained (for review see: Ahmed
et al. 2017; Askew and Chien 2020; Delmaghani and
El-Amraoui 2020; Geleoc and El-Amraoui 2020; Lustig
and Akil 2019)). These findings can be explained by the
low transduction efficiency of conventional AAVs in the
auditory outer hair cells. Recent studies have shown that
three AAVs—AAV2/9-PHPB and two synthetic AAVs,
AAV2/2.m8 and AAV2/Anc80L65—efficiently trans-
duce both inner and outer hair cells (Gyorgy et al. 2019;
Isgrig et al. 2019; Landegger et al. 2017). The design of
other AAVs, with optimized promoters, titers and delivery
routes, is required to improve transduction rates in audi-
tory hair cells and hearing recovery.

Is it an Usher gene, an atypical or an ultra-rare
gene?

Progress in molecular genetics, based on targeted USH
exome or whole-exome sequencing methods, has greatly
increased our understanding of the genetic causes and
pathogenesis of Usher syndrome (Aparisi et al. 2014;
Bonnet et al. 2011, 2016; Fuster-Garcia et al. 2018; Jouret
et al. 2019; Stiff et al. 2020), and has revealed that some
USH gene mutations can be associated with a different
phenotype and Usher subtype. Recent studies have also
revealed some rare cases with clinical manifestations
resembling those of Usher syndrome ("Usher-like" phe-
notype) (Fuster-Garcia et al. 2019) (Nolen et al. 2020).
The causal genes are referred to as "ultra-rare USH genes".
Below, we describe the variants of USH genes associated
with atypical clinical manifestations and summarize the
available data for ultra-rare USH genes.

Usher genes: different mutations, different phenotypes

Mutations of *MYO7A* (Weil et al. 1997), *CDH23* (Bork et al. 2001), *USH1C* (Ouyang et al. 2002), *PCDH15* (Ahmed et al. 2002), *USH1G* (Maria Oonk et al. 2015), and *WHRN* (Mburu et al. 2003) can cause non-syndromic recessive hearing impairment, and *MYO7A* variants are also associated with a non-syndromic dominant form of hearing impairment (Liu et al. 1997b). The severity and progressivity of the phenotype in patients depend on the type of *MYO7A* mutation. DFNA11 patients have less severe post-lingual hearing loss than patients with DFNB2, and DFNB2 patients have variable phenotypes, ranging from profound hearing loss and variable vestibular dysfunction, or a variable age at onset for hearing loss (due to the low efficacy of expression of splicing mutations) to purely congenital profound hearing loss (Liu et al. 1997b, c; Weil et al. 1997). *USH2A* and *CLRN1* variants are associated with non-syndromic retinitis pigmentosa (Khan et al. 2011; Lenassi et al. 2015).

Several variants of the USH1 genes, *MYO7A*, *CDH23*, and *USH1G*, sometimes with digenic inheritance, have been reported to be linked to atypical USH with variable age at onset and severity of the hearing loss and RP. For instance, compound heterozygous pathogenic variants of *MYO7A* were found in two patients diagnosed with atypical USH and presenting with progressive hearing loss and mild RP (Liu et al. 1998b).

Some variants of *MYO7A* and *CDH23* have also been
identified in patients with clinical diagnoses of USH2
(Aparisi et al. 2014; Bonnet et al. 2011; Fuster-Garcia et al.
2018; Zong et al. 2016), and some variants of *USH2A* have
been identified in patients with clinical diagnoses of USH1
and USH3 (Aparisi et al. 2014; Bonnet et al. 2011; Fus-
ter-Garcia et al. 2018; Zong et al. 2016). Some pathogenic
variants of *USH1G* and *CDH23* have also been described
in patients with atypical USH. A missense mutation of
*USH1G*, c.1373A > T p.(Asp458Val), has been reported to
cause atypical USH—mild retinitis pigmentosa with normal
vestibular function—in two families from Turkey with auto-
somal recessive non-syndromic hearing loss (Kalay et al.
2005). Other frameshift mutations of *USH1G* have been
reported to cause an USH1 phenotype (Weil et al. 2003;
Neuhaus et al. 2017; Ouyang et al. 2005). It is, thus, possible
that some missense mutations of *USH1G* result in hypo-
morphic alleles, leading to a less severe phenotype than for
frameshift mutations. However, a biallelic frameshift muta-
tion of *USH1G* was reported in a consanguineous Pakistani
family with four affected individuals presenting moderate-
to-severe hearing loss, mild retinitis pigmentosa and normal
vestibular function, a phenotype similar to that of USH2
patients (Bashir et al. 2010). These studies reveal that the
type or location of the mutation is not always correlated with
the severity of the phenotype. An effect of modifier genes or epigenetic factors cannot be excluded.

Two USH2 genes, *USH2A* and *ADGRV1*, have also been reported to be associated with atypical USH. Mutations of *USH2A* cause USH2A, atypical USH or non-syndromic RP (Aller et al. 2004; Liu et al. 1999b; Neuhaus et al. 2017; Pierrache et al. 2016). Liu et al. reported a frameshift mutation in *USH2A* (c.2314delG/c.2299delG) in patients from 12 families, in four of which atypical USH features were observed, with progressive hearing impairment, variable vestibular function, and RP (Liu et al. 1999b). Several other mutations of this gene have also been reported to cause both USH2 and atypical USH (Aller et al. 2004; Blanco-Kelly et al. 2015; Garcia-Garcia et al. 2011; Neuhaus et al. 2017; Steele-Stallard et al. 2013). As clinical phenotypes are progressive and variable between patients with the same mutation of *USH2A*, other factors, such as age and environment (noise exposure) may account for the phenotypic variations observed in these patients.

Finally, frameshift and missense mutations of *ADGRV1* have been reported in association with typical USH2 symptoms. However, three affected siblings with previously unknown frameshift mutations were reported to have post-lingual hearing loss and an absence of night blindness, a phenotype that is different from the classical USH2 phenotype (Zhang et al. 2018).

Whatever the Usher gene, the various phenotypes observed should be considered from the angle of the causal gene identity, and the predicted impact of the causal mutation on the function of the encoded protein, which may depend on the type and location of the pathogenic variant. The position of the given gene in the Usher interactome, and the way in which its dysfunction would interfere with the functioning of other Usher proteins should also be considered, together with the possible presence of other pathogenic variants or modifier genes. Additive deleterious impacts of several variants and/or functional redundancy may account for the occurrence of a more severe, or a milder phenotype, respectively.

## Ultra-rare Ush forms or just deaf-blindness syndrome?

As mentioned above, several genes associated with Usher syndrome have been reported to result in phenotypes not consistent with the defined clinical subtypes of USH. These genes are referred to as “ultra-rare USH genes” and include *PDZD7* (Eisenberger et al. 2012), *HARS* (Puffenberger et al. 2012), *ABHD12* (Eisenberger et al. 2012), *CIB2* (Riazuddin et al. 2012), *CEP250* (Khateb et al. 2014), *CEP78* (Namburi et al. 2016), *ESPN* (Ahmed et al. 2018), and *ARSG* (Khateb et al. 2018) (see Table 1).

## PDZD7 (PDZD7 domain-containing 7)

*PDZD7* encodes a PDZ scaffold protein found in the ankle-link complexes of hair cell stereocilia (Grati et al. 2012; Morgan et al. 2016; Zou et al. 2014). This gene was first identified as a possible USH gene based on of its high degree of sequence similarity to *USH1C* and *WHRN* (Schneider et al. 2009). Furthermore, in three clinical cases of USH, heterozygous pathogenic variants of *PDZD7* were identified as possible USH disease modifiers and contributors to digenic Usher syndrome (Ebermann et al. 2010). In one family with a homozygous loss-of-function (LOF) variant of *USH2A* and a monoallelic variant of *PDZD7*, the retinal phenotype was more severe. In the second family, a compound heterozygous variants in *USH2A* and a heterozygous variant in *PDZD7* caused milder retinal phenotype. In the third family, monoallelic LOF variants of *ADGRV1* and *PDZD7* led to a severe retinal phenotype (Ebermann et al. 2010) (see Table 1). However, digenic heterozygous mutant mice of *Pdzd7* with *Ush2a*, *Adgrv1* or *Whrn* did not exhibit congenital hearing impairment (Zou et al., 2014), suggesting that the digenic inheritance of two variants in two USH2 complex genes reported in these families was most likely coincidence rather than causal. In the cochlea, *PDZD7* preferentially interacts with *ADGRV1* rather than with *USH2A* (Chen et al. 2014). Moreover, *PDZD7* defects have been shown to affect the localization of the USH2 protein complex in cochlear hair cells, but not in photoreceptors (Zou et al. 2014; Chen et al. 2014; Du et al. 2018). Several biallelic mutations of *PDZD7* have been found to cause non-syndromic recessive mild-to-severe sensorineural hearing loss (Booth et al. 2015; Vona et al. 2016; Guan et al. 2018; Luo et al. 2019; Lee et al. 2019). Interestingly, two Chinese patients with the same variant reported in Ebermann study, c.166_167insC p.(Arg56Profs*24), presented normal retinal and vestibular phenotypes (Guan et al. 2018). The observed divergent phenotypes in former patients may be associated with *USH2A* variants (Ebermann et al. 2010). The knockdown of *Pdzd7* function in zebrafish results in an USH-like phenotype, manifesting as a reduced startle reflex, circling, and disorganized bundles of stereocilia in the cochlea, together with progressive retinal cell death, with a decrease in the amount of *ADGRV1* localizing to the connecting cilia in photoreceptor cells. In contrast, *Ush2a* levels and localization appeared normal in *Pdzd7a* knockdown retinas (Ebermann et al. 2010). Moreover, *Pdzd7*-knockout mice display profound hearing loss and a disorganization of the ankle-link region of the stereocilia in hair bundles, together with weak mechanoelectrical transduction currents and low cochlear hair cell sensitivity (Zou et al. 2014). It has been suggested that, by interacting

<figure><img src="image_11.png" /></figure>
<table><caption>**Table 1** Overview of ultra-rare USH genes reported in the literature</caption><thead><tr><th>Gene (OMIM Ref.)</th><th>Protein product</th><th>Function</th><th>Clinical diagnosis</th><th>Variant(s)</th><th>Population</th><th>References</th></tr></thead><tbody><tr><td>PDZD7 (#612,971)</td><td>PDZD7 domain-containing 7</td><td>Scaffold protein</td><td>USH2</td><td>c.166_167insC p.(Arg56Profs*24); USH2A c.4338_4339del p.(Cys1447Glnfs*29)<br>c.1750-2A > G p.(?); USH2A c.4515_4518 del p.(Arg1505Serfs*7);p.(Thr4439Ile)<br>c.2194_2203del p.(Cys732Leufs*18); ADGRV1 c.17137delG p.(Ala5713Leufs*3)</td><td>French Canadian<br>German<br>German</td><td>Ebermann et al. (2010)</td></tr><tr><td>HARS (#142,810)</td><td>Histidyl-tRNA synthetase</td><td>Aminoacyl-tRNA synthetase</td><td>USH3</td><td>Biallelic c.1361A > C p.(Tyr454Ser)</td><td>Plain population of Pennsylvania, Old Order Amish population of Ontario</td><td>Puffenberger et al. (2012)</td></tr><tr><td>ABHD12 (#613,599)</td><td>α/β-hydrolase domain-containing 12</td><td>Serine hydrolase</td><td>USH</td><td>c.410 G > A p.(Arg137Gln);c.262 G > A p.(Gly88Ser)</td><td>Swiss</td><td>Tiwari et al. (2016)</td></tr><tr><td>ABHD12 (#613,599)</td><td>α/β-hydrolase domain-containing 12</td><td>Serine hydrolase</td><td>PHARC</td><td>Biallelic c.193C > T p.(Arg65*)</td><td>Lebanese</td><td>Eisenberger et al. (2012)</td></tr><tr><td>CIB2 (#605,564)</td><td>Calcium and integrin-binding family member 2</td><td>Calcium sensor</td><td>PHARC</td><td>Biallelic c.316+2A > T p.(?)</td><td>Japanese</td><td>Youshimura et al. (2015)</td></tr><tr><td>CIB2 (#605,564)</td><td>Calcium and integrin-binding family member 2</td><td>Calcium sensor</td><td>Atypical USH</td><td>c.316+5 G > A p.(?);c.477 G > A p.(Trp159*)</td><td>Chinese</td><td>Sun et al. (2018)</td></tr><tr><td>CIB2 (#605,564)</td><td>Calcium and integrin-binding family member 2</td><td>Calcium sensor</td><td>Non-syndromic autosomal recessive RP</td><td>c.319delA p.(Arg107Glufs*8);c.605C > T p.(Thr202Ile)</td><td>Spanish</td><td>Nishiguchi et al. (2014)</td></tr><tr><td>CEP250 (#609,689)</td><td>Centrosomal protein 250</td><td>Centrosomal/ciliary protein</td><td>USH1J</td><td>Biallelic c.192G > C p.(Glu64Asp)</td><td>Pakistani</td><td>Riazuddin et al. (2012)</td></tr><tr><td>CEP250 (#609,689)</td><td>Centrosomal protein 250</td><td>Centrosomal/ciliary protein</td><td>Atypical USH</td><td>Biallelic c.3463C > T p.(Arg1155*); C2orf71 c.3289C > T p.(Gln1097*)</td><td>Iranian Jewish</td><td>Kateb et al. (2014)</td></tr><tr><td>CEP250 (#609,689)</td><td>Centrosomal protein 250</td><td>Centrosomal/ciliary protein</td><td>SNHL with CRD</td><td>c.361C > T p.(Arg121*);c.562C > T p.(Arg188*)</td><td>Japanese</td><td>Kubota et al. (2018)</td></tr><tr><td>CEP250 (#609,689)</td><td>Centrosomal protein 250</td><td>Centrosomal/ciliary protein</td><td>USH-like</td><td>c.4006C > T p.(Arg1336*);c.3337A > T p.(Lys1113*)</td><td>Spanish</td><td>Fuster-García et al. (2018)</td></tr><tr><td>CEP78 (#617,110)</td><td>Centrosomal protein 78</td><td>Centrosomal/ciliary protein</td><td>SNHL with CRD</td><td>Biallelic c.893-1 G > A p.(?)<br>Biallelic c.534delT p.(Leu179Argfs*10)<br>c.893-1 G > A p.(?);c.534delT p.(Leu179Argfs*10)</td><td>Iranian, Iraqi, and Afghan Jewish</td><td>Namburi et al. (2016)</td></tr><tr><td>CEP78 (#617,110)</td><td>Centrosomal protein 78</td><td>Centrosomal/ciliary protein</td><td>SNHL with CRD</td><td>Biallelic c.499+1 G > T p.(?)<br>c.499+5 G > A p.(?);c.633delC p.(Trp212Glyfs*18)</td><td>Greek, Swedish</td><td>Nikopoulos et al. (2016)</td></tr><tr><td>CEP78 (#617,110)</td><td>Centrosomal protein 78</td><td>Centrosomal/ciliary protein</td><td>Atypical USH</td><td>Biallelic c.1254+5 G > A p.(?)<br>Biallelic c.1629-2A > G p.(?)</td><td>Chinese</td><td>Fu et al. (2017)</td></tr><tr><td>CEP78 (#617,110)</td><td>Centrosomal protein 78</td><td>Centrosomal/ciliary protein</td><td>SNHL with CRD</td><td>Biallelic c.449 T > C p.(Leu150Ser)</td><td>Belgian</td><td>Ascari et al. (2020)</td></tr><tr><td>ESPN ? (#606,351)</td><td>Espin</td><td>Actin-bundling protein</td><td>Atypical USH/USH1M</td><td>Biallelic c.2369_2386del p.(Arg790.Arg795del)</td><td>Pakistani</td><td>Ahmed et al. (2018)</td></tr></tbody></table>
<table><caption>**Table 1** (continued)</caption><thead><tr><th>Gene (OMIM Ref.)</th><th>Protein product</th><th>Function</th><th>Clinical diagnosis</th><th>Variant(s)</th><th>Population</th><th>References</th></tr></thead><tbody><tr><td rowspan="10">ARSG (#610,008)</td><td rowspan="10">Arylsulfatase G</td><td rowspan="10">Lysosomal sulfatase</td><td rowspan="10">Atypical USH</td><td>Biallelic c.133G > T p.(Asp45Tyr)</td><td>Yemenite Jewish</td><td>Khateb et al. (2018)</td></tr><tr><td>Biallelic c.130G > A p.(Asp44Asn)</td><td>Spanish</td><td>Abad-Morales et al. (2020)</td></tr><tr><td>Biallelic c.1326del p.(Ser443Alafs*12)</td><td>Portuguese</td><td>Peter et al. (2020)</td></tr><tr><td>c.253 T > C p.(Ser85Pro);c.338G > A p.(Gly113Asp)</td><td></td><td></td></tr><tr><td>Biallelic c.1270C > T p.(Arg424Cys)</td><td>Persian</td><td>Fowler et al. (2021)</td></tr><tr><td>c.283C > T p.(Arg95Trp);c.566 + 3 _566 + 8del p.(?)</td><td>ND</td><td>Igelman et al. (2021)</td></tr><tr><td>c.1004C > T p.(Thr335Met);c.1326del p.(Ser443Alafs*12)</td><td></td><td></td></tr><tr><td>Biallelic c.337G > A p.(Gly113Ser)</td><td></td><td></td></tr><tr><td>c.1212 + 1G > A p.(Val405Ilefs*41);c.275 T > C p.(Leu92Pro)</td><td>Turkish, Caucasian</td><td>Velde et al. (2022)</td></tr><tr><td>c.1326del p.(Ser443Alafs*12);c.1024C > T p.(Arg342Trp) in combination with a heterozygous variant in USH2A c.6524G > A p.(Arg2175His)</td><td></td><td></td></tr><tr><td>c.588C > A p.(Tyr196*);c.705-3940_982 + 2952del p.(Ser235Argfs*29) in combination with heterozygous variants in ADGRVI c.5525-7C > T p.(?); MYO7A c.905G > A p.(Arg302His); PCDH15 c.1098 + 2354G > A p.(?)</td><td></td><td></td></tr></tbody></table>

PHARC polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, RP retinitis pigmentosa, SNHL sensorineural hearing loss, CRD cone-rod dystrophy, ND not determined

New variants in AHBD12, CEP250, and CEP78 have been recently reported in the patients presenting with dual hearing and vision loss (see Igelman et al. 2021)

with both USH1 and USH2 proteins, including myosin VIIa, usherin, ADGRV1 and whirlin, PDZD7 forms part of the USH2 interactome (Du et al. 2018) (see Fig. 3D). PDZD7 can function as a modifier gene for USH, but additional data are required to confirm whether mutations of PDZD7 alone are sufficient to cause Usher syndrome.

## HARS (histidyl-tRNA synthetase)

HARS encodes histidyl-tRNA synthetase (HARS), a homodimeric class IIa aminoacyl tRNA synthetase that charges tRNA molecules with histidine amino acids for protein translation (Antonellis and Green 2008). In 2012, HARS

was reported to be a causal gene for the USH3 phenotype based on a homozygous pathogenic variant found in two patients with hearing and vision impairments (Puffenberger et al. 2012). Compound heterozygous pathogenic variants of HARS were subsequently described in a patient with an undefined type of USH (Tiwari et al. 2016). The subcellular distribution of HARS in the inner ear and retina remains to be determined and it is unknown whether this protein is part of the USH protein network. In addition to typical USH3 symptoms, HARS-affected patients displayed signs of episodic psychosis and neurological symptoms (Puffenberger et al. 2012). The presence of additional symptoms is HARS-affected patients raises the question as to whether HARS is a genuine USH-causing gene.
## ABHD12 (α/β-hydrolase domain-containing 12)

ABHD12 (α/β-hydrolase domain-containing 12) encodes ABHD12, a serine hydrolase that hydrolyzes 2-arachidonoyl glycerol, an endocannabinoid lipid transmitter that acts on the cannabinoid receptors CB1 and CB2 (Eisenberger et al. 2012; Li et al. 2019; Sun et al. 2018). Mutations of ABHD12 have been reported in PHARC syndrome, which is characterized by a combination of polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataracts. However, several biallelic pathogenic variants have been identified in patients clinically diagnosed with USH3-like symptoms or an autosomal recessive non-syndromic form of retinal degeneration (Eisenberger et al. 2012; Nishiguchi et al. 2014; Sun et al. 2018; Yoshimura et al. 2015). One major problem with these studies is that they do not usually include neurological results for the patients, potentially leading to the misdiagnosis of their condition as USH3. In addition, Abhd12-knockout mice display neurodegenerative abnormalities resembling the behavioral phenotypes of human PHARC patients (Blankman et al. 2013). PHARC should, therefore, be considered as a differential diagnosis for patients with USH3-like phenotypes presenting with progressive hearing loss and balance defects. As for HARS, further studies are required to determine the subcellular distribution of ABHD12 in the inner ear and retina, and its interactions with other USH proteins (Fig. 3D), to confirm that there is a genuine association with Usher syndrome.

## CIB2 (calcium and integrin-binding family member 2)

CIB2 encodes an EF domain-containing protein that binds both calcium and integrin. Biallelic mutations of this gene were initially reported to cause non-syndromic recessive deafness (DFNB48) and Usher syndrome (USH1J) (Riazuddin et al. 2012). Only one family with USH1J carrying a CIB2 mutation has been identified to date (Riazuddin et al. 2012). CIB2 is widely transcribed in many tissues, including the inner ear and retina. It is expressed in the stereocilia of auditory hair cells and in the retinal photoreceptor and pigmented epithelium cells (Riazuddin et al. 2012). CIB2 has been shown to interact with two components of the Usher interactome: myosin VIIa (USH1B) and whirlin (USH2D) (Riazuddin et al. 2012) (see Fig. 3D). Sequencing studies on 427 patients with USH led to the identification of biallelic or monoallelic mutations of Usher genes in 421 individuals with USH, but no CIB2

mutations were detected in any of these patients (Bonnet et al. 2016). In recent years, several pathogenic variants of CIB2 were identified after the discovery of USH1J, in families with the DFNB48 form of isolated deafness but no signs of retinitis pigmentosa or vestibular dysfunction (Patel et al. 2015; Seco et al. 2016; Michel et al. 2017; Booth et al. 2018; Souissi et al. 2021). Morphofunctional analyses of the inner ear in Cib2<sup>-/-</sup> mice showed that a lack of Cib2 leads to abnormal auditory hair bundle shape and an absence of mechanoelectrical transduction responses in cochlear hair cells (Giese et al. 2017; Liang et al. 2021; Michel et al. 2017; Wang et al. 2017). Unlike mice defective for any of the five unequivocal USH1 genes, Cib2<sup>-/-</sup> mice have no vestibular defect (Giese et al. 2017; Michel et al. 2017; Wang et al. 2017). However, a thorough longitudinal study in conditional Cib2<sup>flox/flox</sup>; RPE-Cre+ mice showed that specific inactivation of Cib2 in the subretinal pigment epithelium (RPE) cells led to age-related retinal phenotypes (Sethna et al. 2021a). It has been suggested that Cib2 loss leads to dysregulated mTORC1 signaling and a decrease in autophagy, resulting in RPE cells dysfunction and secondary photoreceptor dysfunction (Sethna et al. 2021a). These abnormalities trigger an age-related decline of retinal functions manifesting as RPE deposits, a marked accumulation of drusen (extra-cellular lesions characteristic of dry age-related macular degeneration) and impaired visual function (Sethna et al. 2021a). Caution is, therefore, required when providing genetic counseling for patients carrying CIB2 mutations. These mutations may not lead to Usher syndrome, but the possibility of some types of CIB2 mutations conferring predisposition to age-related macular degeneration should be considered.

## CEP250 (centrosomal protein 250)

CEP250 encodes ciliary protein C-NAP1, a member of the CEP family (Kumar et al. 2013). This protein family has more than 30 members, which form the core component of the centrosome and play crucial roles in centriole biogenesis, centrosome cohesion, and the control of cell-cycle progression (Kumar et al. 2013). CEP250 is expressed in the photoreceptor outer segment and involved in retinal ciliogenesis (de Castro-Miro et al. 2016). In 2014, Khateb et al. identified a homozygous pathogenic variant of CEP50 in a family affected by an USH-like condition, with mild RP and early-onset hearing loss (Khateb et al. 2014). However, the patients in this family also carried a monoallelic or biallelic mutation of C2orf71, encoding a ciliary protein associated with autosomal recessive RP. Patients double-homozygous for the mutations of both genes had a more severe phenotype, indicating an additive effect of the dysfunctions of
these two ciliary proteins due to nonsense mutations (Khateb et al. 2014). Furthermore, compound heterozygous muta- tions of *CEP250* have been reported in patients, manifesting as mild cone–rod dystrophy and neurosensorial hearing loss (Kubota et al. 2018). Two heterozygous nonsense mutations of *CEP250* have also been reported in a patient presenting with an Usher-like phenotype (Fuster-Garcia et al. 2018). However, progressive hearing loss in this patient was asso- ciated with late-onset visual impairment due to cone–rod dystrophy (Fuster-Garcia et al. 2018), contrasting with the typical rod–cone dystrophy of USH patients. A nonsense mutation of *CEP250* has been reported in a consanguineous family with retinitis pigmentosa with no hearing or vestibub- lar impairment (Huang et al. 2019). The study of *Cep250-* knock-in mice harboring the same mutation showed that a lack of Cep250 leads to severe retinal degeneration. Cep250 defects affect cilium and protein localization in the outer segments of photoreceptor cells, significantly decreasing ret- inal thickness and ERG responses. This finding confirms the crucial role of CEP250 in photoreceptor cilium development and function (Huang et al. 2019), but the potential func- tion of CEP250 in the inner ear and its possible interactions with other proteins of the Usher network remain unknown (Fig. 3D).

## CEP78 (centrosomal protein 78)

CEP78 is a ciliary gene encoding CEP78, another member of the CEP family of proteins localizing to the centriole wall. Its interaction with the N-terminal catalytic domain of PLK4, a serine/threonine polo-like kinase, is impor- tant for PLK4-induced centrosome overduplication and cell-cycle regulation (Brunk et al. 2016). CEP78 is found in the photoreceptor-connecting cilium, with a stronger signal in cones than in rods (Namburi et al. 2016; Niko- poulos et al. 2016). The CEP78 transcript is also present in the human cochlea (Nikopoulos et al. 2016). As for CEP250, several biallelic pathogenic variants of CEP78 have been reported in patients presenting with progressive and late-onset cone–rod degeneration and hearing loss (Fu et al. 2017; Namburi et al. 2016; Nikopoulos et al. 2016). However, pathogenic variants of CEP78 may be associ- ated with phenotypes other than typical USH-like phe- notypes. For instance, a homozygous CEP78-truncating variant was identified in a family diagnosed with autoso- mal recessive non-syndromic RP (de Castro-Miro et al. 2016). Ascar et al (2020) identified a missense mutation of CEP78 in the homozygous and compound heterozy- gous states in three unrelated families displaying cone–rod retinal degeneration and hearing loss, with and without male infertility (Ascar et al. 2020). Given the complete characterization of the clinical phenotype in these studies,

CEP78- and CEP250-affected patients can be classified as a distinct group with a “cone–rod degeneration and senso- rineural hearing loss” syndrome rather than an Usher-like condition.

## ESPN (espin)

ESPN encodes espin, a calcium-insensitive actin-bundling protein essential for hearing and vestibular function. A frameshift mutation affecting the espin C-terminal actin- bundling module causes deafness and vestibular behavioral defects accompanied by stereocilium shortening and disor- ganization in the jerker mouse (Zheng et al. 2000). Espin is localized in the stereocilia of auditory and vestibular hair cells (Sekerkova et al. 2006; Zheng et al. 2000) and in the photoreceptor calyceal processes (Sahly et al. 1997), where it plays an essential role in actin filament crosslink- ing to control the length and integrity of microvillar apical membranes. Furthermore, an in-frame deletion of ESPN was reported to underlie atypical USH1 in a Pakistani fam- ily (Ahmed et al. 2018). All the patients from this family had hearing loss, vestibulopathy, progressive retinal abnor- malities and vision impairment, including temporal flecks (delayed dark adaptation with an irregular retinal contour), optic disk pallor and weak scotopic ERG responses (Ahmed et al. 2018). Espin has been shown to interact with whirlin, and its expression is altered in the photoreceptors and hair cells of whirlin-deficient mice (Wang et al. 2012), linking this protein to the hair bundle-based Usher interactome (see Fig. 3D). However, unlike the loss-of-function mutations of other USH1 genes, biallelic frameshift mutations of ESPN in humans cause only non-syndromic prelingual hearing loss (DFNB36) and vestibular areflexia without vision impair- ment (Naz et al. 2004). Several pathogenic variants have also been reported in patients with autosomal dominant pro- gressive hearing loss without vestibular or vision deficits (Donaudy et al. 2006). Additional information is required about the pathogenic impact of the in-frame ESPN mutation, which is considered to be an atypical Usher variant, and whether it is causal for all the clinical symptoms observed in ESPN-affected patients (Ahmed et al. 2018). On fundoscopy, patients of about 30 years of age with ESPN mutations do not display the typical RP observed in age-matched USH1 patients (Ahmed et al. 2018). The preserved normal cone function in the retina of an affected 42-year-old deaf indi- vidual, and the occurrence of cardiac abnormalities in other affected patients remain unexplained (Ahmed et al. 2018). The type of mutation may account for variability in the phe- notype of patients in these studies, but the possible effects of another pathogenic variant causing retinal impairment, age, and environmental factors should be considered.

<figure><img src="image_12.png" /></figure>
## ARSG (arylsulfatase G)

ARSG encodes arylsulfatase G, a lysosomal sulfatase widely expressed in various human tissues and involved in diverse metabolic pathways (Ferrante et al., 2002). Arsg deficiency in a knockout mouse model of mucopolysaccharidosis IIIE results in ataxia, a progressive degeneration of rod photoreceptor cells accompanied by reactive astrogliosis and microgliosis, and a dysregulation of several lysosomal proteins (Kowalewski et al. 2015). A homozygous founder variant of ARSG has been reported in patients from three families of Yemenite Jewish origin suffering from an atypical form of late-onset hearing and vision impairments, referred to as atypical USH (Khateb et al. 2018). The patients displayed moderate-to-severe sensorineural hearing loss and a retinal degeneration phenotype, with ring-shaped atrophy along the arcades surrounding the fovea, resulting in ring scotoma (Khateb et al. 2018). Furthermore, several additional pathogenic variants have been reported to be associated with this deaf-blindness syndrome (see Table 1) (Abad-Morales et al. 2020; Fowler et al. 2021; Igelman et al. 2021; Khateb et al. 2018; Peter et al. 2021; Velde et al. 2022), All ARSG-affected patients were diagnosed with RP with a midlife age of onset (35–60 years) (Abad-Morales et al. 2020; Fowler et al. 2021; Igelman et al. 2021; Khateb et al. 2018; Peter et al. 2021; Velde et al. 2022), which is later than generally seen in classical Usher forms. Also, the ARSG late-onset RP is predominantly pericentral, accompanied by macular changes (Abad-Morales et al. 2020; Fowler et al. 2021; Igelman et al. 2021; Khateb et al. 2018; Peter et al. 2021; Velde et al. 2022), distinct from the typical Usher rod-cone dystrophy. As for hearing loss, all but one previously described individuals (Igelman et al. 2021) display progressive mild, moderate-to-severe hearing loss with a self-reported onset ranging from childhood to 50 years (Abad-Morales et al. 2020; Fowler et al. 2021; Igelman et al. 2021; Khateb et al. 2018; Peter et al. 2021; Velde et al. 2022). Unlike USH patients that benefit from cochlear implants (Davies et al. 2021), ARSG-affected individuals rely on hearing aids, which starts at varying ages ranging from 18 to 67 years (Abad-Morales et al. 2020; Fowler et al. 2021; Igelman et al. 2021; Khateb et al. 2018; Peter et al. 2021; Velde et al. 2022). The dual occurrence of late-onset hearing impairment and vision loss in ARSG phenotype is consistent among patients, confirming that ARSG LOF variants do lead to a deaf-blindness syndrome. So far, there is no evidence of ARSG association with non-syndromic vision or hearing loss. The unique RP and hearing phenotypic features due to ARSG LOF variants (Abad-Morales et al. 2020; Fowler et al. 2021; Igelman et al. 2021; Khateb et al. 2018; Peter et al. 2021;

Velde et al. 2022) and lack of connection with Usher proteins (see Fig. 3D) make the designation as Usher type IV unnecessary. Unlike the phenotype in the knockout mice (Kowalewski et al. 2015; Kruszewski et al. 2016) and ARSG-deficient dogs (Abitbol et al. 2010), none of ARSG-affected patients show any signs of lysosomal storage defects in peripheral organs or central nervous system involvement (Abad-Morales et al. 2020; Fowler et al. 2021; Igelman et al. 2021; Khateb et al. 2018; Peter et al. 2021; Velde et al. 2022). The precise function of ARSG in the retina and the inner ear remain to be established. Also, attention should also be paid to occurrence of other phenotypes, such as a medical history of hypothyroidism observed in two ARSG-affected patients (Velde et al. 2022).

In conclusion, to clarify the diagnosis of Usher syndrome, there is growing evidence that strict adherence to the clinical criteria for Usher syndrome is essential for the correct diagnosis of this condition. In addition to clinical information about hearing and vision, detailed information about vestibular function is required for a patient to be considered to have USH1. The presence of retinal degeneration classified as a rod-cone dystrophy is also a key criterion for the diagnosis of Usher syndrome. Attention should be paid to the presence of symptoms affecting additional organ systems, which could be signs that the disease falls within other syndromic deaf-blindness disorders. Once a defective gene is identified, available or predictive information about the function of the defective protein in the inner ear and the eye, in humans or animal models (cf. below), and its potential interactions with known Usher proteins should guide the decision as to whether the gene can be considered or maintained as an Usher gene.

## Conclusion and proposal of a new, revised classification for Usher syndrome

With growing access to advanced genomic sequencing, a wealth of additional pathogenic variants of known USH genes (or other genes) are being identified in patients with hearing and vision loss (Bonnet et al. 2016; Lenarduzzi et al. 2019; Bolz 2020; Nolen et al. 2020; Stiff et al. 2020; Nisenbaum et al. 2021; Castiglione and Moller 2022). The previous three-category classification was based exclusively on clinical criteria, but the co-occurrence of hearing and vision deficits, of any type, should not be the only criterion for the diagnosis of Usher syndrome. We agree with several other researchers and clinicians (Bolz 2020; Nolen et al. 2020; Stiff et al. 2020; Nisenbaum et al. 2021) that the time has come to revisit and complement the traditional Usher syndrome classification.
The use of all available criteria and data on disease-caus-
ing genes should make it possible to establish clear diagno-
ses without blurring the boundaries between Usher and non-
Usher forms of deaf-blindness, and this will be of benefit
to the clinicians, scientists, and patients. With the advent of
precision medicine, all the available information on clinical
symptoms, genotype-phenotype correlations, interactions
within the Usher molecular network, and precise pathogenic
events in animal models could be considered to determine
whether pathogenic variants should be considered causal for
Usher syndrome. Based on clinical, genetic, network, and
disease model findings for the founding forms of Usher syn-
drome, USH1, USH2 and USH3 (see Figs. 4, 5), and those
for additional so-called ‘USH-like’ genes, we propose to
consider *MYO7A*, *USH1C*, *PCDH15*, *CDH23*, and *USH1G*
as the only USH1 genes, *USH2A*, *ADGRV1*, and *WHRN* as
the only USH2 genes, and *CLRN1* as the causal gene for
USH3. Depending on the type and location of the causal
variant, it is not uncommon to observe variations of clini-
cal expression in rare diseases. The variety of phenotypic
expression in patients carrying USH gene mutations should,
therefore, be explained and accepted within the spectrum of
Usher syndrome; the inference of atypical Usher forms is
unnecessary. New guidelines are probably needed to estab-
lish clear consensus criteria for the diagnosis of USH and
the inclusion of new genes as actual “USH” genes. *PDZD7*
may act as a modifier gene for USH, but *HARS*, *ABHD12*,
*CIB2*, *CEP250*, *CEP78*, *ESPN*, and *ARSG* could be grouped
in a separate syndromic “deaf-blindness” category, to avoid
diagnostic pitfalls and misinformation during genetic coun-
seling for Usher syndrome. Providing an early and accurate
diagnosis is essential for Usher syndrome, to ensure appro-
priate patient management choices for personalized treat-
ment and interventions. Particularly for patients with USH1,
the most severe form, early diagnosis makes it possible to
fit cochlear implants to alleviate the burden of hearing loss,
and to start monitoring for retinitis pigmentosa early, as the
progression of this condition would affect the performance
of the implant if the ability to lip-read were lost. Detailed
clinical investigations should be performed for hearing, bal-
ance, and vision, to establish optimal genotype-phenotype
correlations, not only according to the identity of the causal
gene but also taking the nature and severity of the muta-
tion into account. Careful attention should also be paid to
the presence of “mono or biallelic” additional mutations in
potentially co-segregating genes that may account for the
variable spectrum of clinical symptoms. The accumulation
of data over time might help to establish predictive mod-
els for the spectrum of disease symptoms, their progres-
sion and severity. Recent progress towards elucidating the
mechanisms of Usher disease is fueling an intensification
of efforts to develop various therapeutic strategies and to
establish clinical trials for Usher syndrome, with approaches

including gene replacement, gene editing, antisense oligonucleotides, and small-molecule drugs (Williams et al. 2017; Geleoc and El-Amraoui 2020; Delmaghani and El-Amraoui 2020; Toms et al. 2020b; Botto et al. 2021; Dinculescu et al. 2021). Success for these promising therapies, the clarity of diagnosis, and the dissemination of more precise messages to researchers, clinicians, ENT specialists, ophthalmologists and all those working in sensory fields will be transformative, fostering the rapid transfer of today’s promises into future clinical applications for patients.

**Acknowledgements** We thank Emilia Wysocka for the in silico analysis on Usher interactome (cf. Fig 3D) and Audrey Maudoux for critical reading of the manuscript. The work in the authors' laboratories is funded by the French National Research Agency (ANR), as part of the second "Investissements d'Avenir" program (light4deaf, ANR-15-RHUS-0001), and LabEx LIFESENSES (ANR-10-LABX-65), ANR-HearInNoise (ANR-17-CE16-0017), EuroNanoMed-NanoEar (ANR-21-ENM3-0003-04), LHW-Stiftung, Fondation de France, Fondation Maladies Rares, Retina-France, and Fondation pour l'Audition (FPA-19-Stg). We acknowledge the support provided to the Institut de l'Audition by Fondation pour l'Audition. We also apologize to authors of any relevant references whose work was not cited due to space constraints.

**Author contributions** SD and AE wrote the manuscript. All the authors have read and agreed to the submission of the published version of the manuscript.

**Funding** The work in the authors' laboratories was funded by the French National Research Agency (ANR), as part of the second "Investissements d'Avenir" program (light4deaf, ANR-15-RHUS-0001), and LabEx LIFESENSES (ANR-10-LABX-65), ANR-HearInNoise (ANR-17-CE16-0017), EuroNanoMed-NanoEar (ANR-21-ENM3-0003-04), LHW-Stiftung, Fondation de France, Fondation Maladies Rares, Retina-France, and Fondation pour l'Audition (FPA-19-Stg).

**Availability of data and material** Not applicable.

**Code availability** Not applicable.

**Declarations**

**Conflict of interest** The authors have no competing interest to declare.

**Ethical approval** Not applicable.

**Consent to participate** Not applicable.

**Consent for publication** Not applicable.

**Open Access** This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

References

Abadie C, Blanchet C, Baux D, Larrieu L, Besnard T, Ravel P, Biboulet R, Hamel C, Malcolm S, Mondain M, Claustres M, Roux AF (2012) Audiological findings in 100 USH2 patients. Clin Genet 82:433–438. https://doi.org/10.1111/j.1399-0004.2011.01772.x

Abad-Morales V, Navarro R, Bures-Jelstrup A, Pomares E (2020) Identification of a novel homozygous ARSG mutation as the second cause of Usher syndrome type 4. Am J Ophthalmol Case Rep 19:100736. https://doi.org/10.1016/j.ajoc.2020.100736

Abitbol M, Thibaud JL, Olby NJ, Hitte C, Puech JP, Maurer M, Pilot-Storck F, Hedan B, Dreano S, Brahimi S, Delattre D, Andre C, Gray F, Delisle F, Caillaud C, Bernex F, Panthier JJ, Aubin-Houzelstein G, Blot S, Tiret L (2010) A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis. Proc Natl Acad Sci U S A 107:14775–14780. https://doi.org/10.1073/pnas.0914206107

Adato A, Lefevre G, Delprat B, Michel V, Michalski N, Chardenoux S, Weil D, El-Amraoui A, Petit C (2005a) Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. Hum Mol Genet 14:3921–3932

Adato A, Michel V, Kikkawa Y, Reiners J, Alagramam KN, Weil D, Yonekawa H, Wolfrum U, El-Amraoui A, Petit C (2005b) Interactions in the network of Usher syndrome type 1 proteins. Hum Mol Genet 14:347–356. https://doi.org/10.1093/hmg/ddi031

Adato A, Vreugde S, Joensuu T, Avidan N, Hamalainen R, Belenkiy O, Olender T, Bonne-Tamir B, Ben-Asher E, Espinos C, Millan JM, Lehesjoki AE, Flannery JG, Avraham KB, Pietrokovski S, Sankila EM, Beckmann JS, Lancet D (2002) USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses. Eur J Hum Genet 10:339–350

Ahmed H, Shubina-Oleinik O, Holt JR (2017) Emerging gene therapies for genetic hearing loss. J Assoc Res Otolaryngol 18:649–670. https://doi.org/10.1007/s10162-017-0634-8

Ahmed ZM, Jaworek TJ, Sarangdhar GN, Zheng L, Gul K, Khan SN, Friedman TB, Sisk RA, Bartles JR, Riazuddin S, Riazuddin S (2018) Inframe deletion of human ESPN is associated with deafness, vestibulopathy and vision impairment. J Med Genet 55:479–488. https://doi.org/10.1136/jmedgenet-2017-105221

Ahmed ZM, Riazuddin S, Bernstein SL, Ahmed Z, Khan S, Griffith AJ, Morell RJ, Friedman TB, Riazuddin S, Wilcox ER (2001) Mutations of the protocadherin gene *PCDH15* cause Usher syndrome type 1F. Am J Hum Genet 69:25–34

Ahmed ZM, Smith TN, Riazuddin S, Makishima T, Ghosh M, Bokhari S, Menon PS, Deshmukh D, Griffith AJ, Friedman TB, Wilcox ER (2002) Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC. Hum Genet 110:527–531

Aller E, Jaijo T, Oltra S, Alio J, Galan F, Najera C, Beneyto M, Mil-lan JM (2004) Mutation screening of USH3 gene (clarin-1) in Spanish patients with Usher syndrome: low prevalence and phe-notypic variability. Clin Genet 66:525–529. https://doi.org/10. 1111/j.1399-0004.2004.00352.x

Antonellis A, Green ED (2008) The role of aminoacyl-tRNA syn- thetases in genetic diseases. Annu Rev Genomics Hum Genet 9:87–107. https://doi.org/10.1146/annurev.genom.9.081307. 164204

Aparisi MJ, Aller E, Fuster-Garcia C, Garcia-Garcia G, Rodrigo R, Vazquez-Manrique RP, Blanco-Kelly F, Ayuso C, Roux AF, Jaijo T, Millan JM (2014) Targeted next generation sequencing for molecular diagnosis of Usher syndrome. Orphanet J Rare Dis 9:168. https://doi.org/10.1186/s13023-014-0168-7

Ascari G, Peelman F, Farinelli P, Rosseel T, Lambrechts N, Wunderlich KA, Wagner M, Nikopoulos K, Martens P, Balikova I, Derycke L, Holtappels G, Krysko O, Van Laethem T, De Jaegere S, Guillemyn B, De Rycke R, De Bleecker J, Creytens D, Van Dorpe J, Gerris J, Bachert C, Neuhofer C, Walraedt S, Bischoff A, Pedersen LB, Klopstock T, Rivolta C, Leroy BP, De Baere E, Coppieters F (2020) Functional characterization of the first mis-sense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility. Hum Mutat 41:998–1011. https://doi.org/10.1002/humu.23993

Askew C, Chien WW (2020) Adeno-associated virus gene replacement for recessive inner ear dysfunction: progress and challenges. Hear Res. https://doi.org/10.1016/j.heares.2020.107947

Bahloul A, Michel V, Hardelin J-P, Nouaille S, Hoos S, Houdusse A, England P, Petit C (2010) Cadherin-23, myosin VIIa and har-monin, encoded by Usher syndrome type I genes, form a ternary complex and interact with membrane phospholipids. Hum Mol Genet 19:3557–3565

Bashir R, Fatima A, Naz S (2010) A frameshift mutation in SANS results in atypical Usher syndrome. Clin Genet 78:601–603. https://doi.org/10.1111/j.1399-0004.2010.01500.x

Ben-Yosef T, Friedman TB (2003) The genetic bases for syndromic and nonsyndromic deafness among Jews. Trends Mol Med 9:496–502. https://doi.org/10.1016/j.molmed.2003.09.004

Besharse JC, Wetzel MG (1995) Immunocytochemical localization of
opsin in rod photoreceptors during periods of rapid disc assem-
bly. J Neurocytol 24:371–388

Blanco-Kelly F, Jaijo T, Aller E, Avila-Fernandez A, Lopez-Molina MI, Gimenez A, Garcia-Sandoval B, Millan JM, Ayuso C (2015) Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients. JAMA Ophthalmol 133:157–164. https://doi.org/10.1001/jamaophthalmol.2014.4498

Blankman JL, Long JZ, Trauger SA, Siuzdak G, Cravatt BF (2013) ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc Natl Acad Sci U S A 110:1500–1505. https://doi.org/10.1073/pnas.1217121110

Boeda B, El-Amraoui A, Bahloul A, Goodyear R, Daviet L, Blanchard S, Perfettini I, Fath KR, Shorte S, Reiners J, Houdusse A, Legrain P, Wolfrum U, Richardson G, Petit C (2002) Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle. EMBO J 21:6689–6699

Bolz H, von Brederlow B, Ramirez A, Bryda EC, Kutsche K, Nothwang HG, Seeliger M, del Maria CSC, Vila MC, Molina OP, Gal A, Kubisch C (2001) Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat Genet 27:108–112. https://doi.org/10.1038/83667

Bolz HJ (2020) Usher syndrome: diagnostic approach, differential diagnoses and proposal of an updated function-based genetic classification. Med Gen. https://doi.org/10.1515/medgen-2020-2023

Bonnet C, El-Amraoui A (2012) Usher syndrome (sensorineural deafness and retinitis pigmentosa): pathogenesis, molecular diagnosis and therapeutic approaches. Curr Opin Neurol 25:42–49. https://doi.org/10.1097/WCO.0b013e32834ef8b2

Bonnet C, Grati M, Marlin S, Levilliers J, Hardelin JP, Parodi M, Niasme-Grare M, Zelenika D, Delepine M, Feldmann D, Jonard L, El-Amraoui A, Weil D, Delobel B, Vincent C, Dollfus H, Eliot MM, David A, Calais C, Vigneron J, Montaut-Verient B, Bonneau D, Dubin J, Thauvin C, Duvillard A, Francannet C, Mom
T, Lacombe D, Duriez F, Drouin-Garraud V, Thuillier-Obstoy MF, Sigaudy S, Frances AM, Collignon P, Challe G, Couderc R, Lathrop M, Sahel JA, Weissenbach J, Petit C, Denoyelle F (2011) Complete exon sequencing of all known Usher syndrome genes greatly improves molecular diagnosis. Orphanet J Rare Dis 6:21. https://doi.org/10.1186/1750-1172-6-21

Bonnet C, Riahi Z, Chantot-Bastaraud S, Smagghe L, Letexier M, Marcaillou C, Lefevre GM, Hardelin JP, El-Amraoui A, Singh-Estivalet A, Mohand-Said S, Kohl S, Kurtenbach A, Sliesoraityte I, Zobor D, Gherbi S, Testa F, Simonelli F, Banfi S, Fakin A, Glavac D, Jarc-Vidmar M, Zupan A, Battelino S, Martorell Sampol L, Claveria MA, Catala Mora J, Dad S, Moller LB, Rodriguez Jorge J, Hawlina M, Auricchio A, Sahel JA, Marlin S, Zrenner E, Audo I, Petit C (2016) An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients. Eur J Hum Genet 24:1730–1738. https://doi.org/10.1038/ejhg.2016.99

Booth KT, Azaiez H, Kahrizi K, Simpson AC, Tollefson WT, Sloan CM, Meyer NC, Babanejad M, Ardalani F, Arzhangi S, Schnieders MJ, Najmabadi H, Smith RJ (2015) PDZD7 and hearing loss: more than just a modifier. Am J Med Genet A 167A:2957–2965. https://doi.org/10.1002/ajmg.a.37274

Booth KT, Kahrizi K, Babanejad M, Daghagh H, Bademci G, Arzhangi S, Zareabdollahi D, Duman D, El-Amraoui A, Tekin M, Najmabadi H, Azaiez H, Smith RJ (2018) Variants in CIB2 cause DFNB48 and not USH1J. Clin Genet 93:812–821. https://doi.org/10.1111/cge.13170

Bork JM, Peters LM, Riazzuddin S, Bernstein SL, Ahmed ZM, Ness SL, Polomeno R, Ramesh A, Schloss M, Srisailpathy CRS, Wayne S, Bellman S, Desmukh D, Ahmed Z, Khan SN, Der Kaloustian VM, Li XC, Lalwani A, Riazzuddin S, Bitner-Glindzicz M, Nance WE, Liu X-Z, Wistow G, Smith RJH, Griffith AJ, Wilcox ER, Friedman TB, Morell RJ (2001) Usher syndrome 1D and non-syndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet 68:26–37

Botto C, Dalkara D, El-Amraoui A (2021) Progress in gene editing tools and their potential for correcting mutations underlying hearing and vision loss. Front Gene Ed 3:737632. https://doi.org/10.3389/fged.2021.737632

Bowl MR, Dawson SJ (2015) The mouse as a model for age-related hearing loss - a mini-review. Gerontology 61:149–157. https://doi.org/10.1159/000368399

Brown PK, Gibbons IR, Wald G (1963) The visual cells and visual pigment of the mudpuppy, *Necturus*. J Cell Biol 19:79–106

Brunk K, Zhu M, Barenz F, Kratz AS, Haselmann-Weiss U, Antony C, Hoffmann I (2016) Cep78 is a new centriolar protein involved in Plk4-induced centriole overduplication. J Cell Sci 129:2713–2718. https://doi.org/10.1242/jcs.184093

Caberlotto E, Michel V, de Monvel JB, Petit C (2011) Coupling of the mechanotransduction machinery and F-actin polymerization in the cochlear hair bundles. BioArchitecture 1:169–174. https://doi.org/10.4161/bioa.1.4.17532

Cadoni SDC, Provansal M, Nguyen D, Nelidova D, Labernede G, Alcala I, Lubetzki J, Goulet R, Burban E, Dégardin J, Simonutti M, Gauvain G, Arcizet F, Marre O, Dalkara D, Roska B, Sahel JA, Tanter M, Picaud S (2021) Sonogenetic stimulation of the brain at a spatiotemporal resolution suitable for vision restoration. BioRxiv. https://doi.org/10.1101/2021.11.07.467597

Castiglione A, Moller C (2022) Usher syndrome. Audiol Res 12:42–65. https://doi.org/10.3390/audiolres12010005

Chen Q, Zou J, Shen Z, Zhang W, Yang J (2014) Whirlin and PDZ domain-containing 7 (PDZD7) proteins are both required to form the quaternary protein complex associated with Usher syndrome type 2. J Biol Chem 289:36070–36088. https://doi.org/10.1074/jbc.M114.610535

Chien WW, Isgrig K, Roy S, Belyantseva IA, Drummond MC, May LA, Fitzgerald TS, Friedman TB, Cunningham LL (2016) Gene therapy restores hair cell stereocilia morphology in inner ears of deaf whirler mice. Mol Ther 24:17–25. https://doi.org/10.1038/mt.2015.150

Cohen AI (1963) Vertebrate retinal cells and their organization. Biol Rev Cambridge Philos Soc 38:427–459

Cosgrove D, Zallocchi M (2014) Usher protein functions in hair cells and photoreceptors. Int J Biochem Cell Biol 46:80–89. https://doi.org/10.1016/j.biocel.2013.11.001

Crane R, Conley SM, Al-Ubaidi MR, Naash MI (2021) Gene therapy to the retina and the cochlea. Front Neurosci 15:652215. https://doi.org/10.3389/fnins.2021.652215

Davies C, Bergman J, Misztal C, Ramchandran R, Mittal J, Bulut E, Shah V, Mittal R, Eshraghi AA (2021) The outcomes of cochlear implantation in Usher syndrome: a systematic review. J Clin Med. https://doi.org/10.3390/jcm10132915

de Castro-Miro M, Tonda R, Escudero-Ferruz P, Andres R, Mayor-Lorenzo A, Castro J, Ciccioli M, Hidalgo DA, Rodriguez-Ezcurra JJ, Farrando J, Perez-Santonja JJ, Corman B, Marfany G, Gonzalez-Duarte R (2016) Novel candidate genes and a wide spectrum of structural and point mutations responsible for inherited retinal dystrophies revealed by exome sequencing. PLoS ONE 11:e0168966. https://doi.org/10.1371/journal.pone.0168966

Delmaghani S, El-Amraoui A (2020) Inner ear gene therapies take off: current promises and future challenges. J Clin Med. https://doi.org/10.3390/jcm9072309

Dinculescu A, Link BA, Saperstein DA (2021) Retinal gene therapy for Usher syndrome: current developments, challenges, and perspectives. Int Ophthalmol Clin 61:109–124. https://doi.org/10.1097/IOI.0000000000000378

Dona M, Slijkerman R, Lerner K, Broekman S, Wegner J, Howat T, Peters T, Hetterschijt L, Boon N, de Vrieze E, Sorusch N, Wolfrum U, Kremer H, Neuhausss S, Zang J, Kamermans M, Westerfield M, Phillips J, van Wijk E (2018) Usherin defects lead to early-onset retinal dysfunction in zebrafish. Exp Eye Res 173:148–159. https://doi.org/10.1016/j.exer.2018.05.015

Donaudy F, Zheng L, Ficarella R, Ballana E, Carella M, Melchionda S, Estivill X, Bartles JR, Gasparini P (2006) Espin gene (ESPN) mutations associated with autosomal dominant hearing loss cause defects in microvillar elongation or organisation. J Med Genet 43:157–161. https://doi.org/10.1136/jmg.2005.032086

Du H, Ren R, Chen P, Xu Z, Wang Y (2018) Identification of binding partners of deafness-related protein PDZD7. Neural Plast 2018:2062346. https://doi.org/10.1155/2018/2062346

Dulla K, Slijkerman R, van Diepen HC, Albert S, Dona M, Beumer W, Turunen JJ, Chan HL, Schulkens IA, Vorthoren L, den Besten C, Buil L, Schmidt I, Miao J, Venselaar H, Zang J, Neuhausss SCF, Peters T, Broekman S, Pennings R, Kremer H, Platenburg G, Adamson P, de Vrieze E, van Wijk E (2021) Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations. Mol Ther 29:2441–2455. https://doi.org/10.1016/j.ymthe.2021.04.024

Dulon D, Papal S, Patni P, Cortese M, Vincent PF, Tertrais M, Emp-toz A, Tlili A, Bouleau Y, Michel V, Delmaghani S, Aghaie A, Pepermans E, Alegria-Prevot O, Akil O, Lustig L, Avan P, Safieddine S, Petit C, El-Amraoui A (2018) Clarin-1 gene transfer rescues auditory synaptopathy in model of Usher syndrome. J Clin Invest 128:3382–3401. https://doi.org/10.1172/JCI94351

Ebermann I, Phillips JB, Liebau MC, Koenekoop RK, Schermer B, Lopez I, Schafer E, Roux AF, Dafinger C, Bernd A, Zrenner E, Claustres M, Blanco B, Nurnberg G, Nurnberg P, Ruland R, Westerfield M, Benzing T, Bolz HJ (2010) PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. J Clin Invest 120:1812–1823. https://doi.org/10.1172/JCI39715
Ebermann I, Scholl HP, Charbel Issa P, Bercovic E, Lamprecht J, Jurklies B, Millan JM, Aller E, Mitter D, Bolz H (2007) A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. *Hum Genet* 121:203–211. https://doi.org/10.1007/s00439-006-0304-0

Eisenberger T, Slim R, Mansour A, Nauck M, Nurnberg G, Nurnberg P, Decker C, Dafinger C, Ebermann I, Bergmann C, Bolz HJ (2012) Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3. *Orphanet J Rare Dis* 7:59. https://doi.org/10.1186/1750-1172-7-59

El-Amraoui A, Petit C (2005) Usher I syndrome: unravelling the mechanisms that underlie the cohesion of the growing hair bundle in inner ear sensory cells. *J Cell Sci* 118:4593–4603. https://doi.org/10.1242/jcs.02636

El-Amraoui A, Petit C (2014) The retinal phenotype of Usher syndrome: pathophysiological insights from animal models. *C R Biol* 337:167–177. https://doi.org/10.1016/j.crvi.2013.12.004

El-Amraoui A, Schonn J-S, Küssel-Andermann P, Blanchard S, Desnos C, Henry J-P, Wolfrum U, Darchen F, Petit C (2002) MyRIP, a novel Rab effector, enables myosin VIIa recruitment to retinal melanosomes. *EMBO Rep* 3:463–470

Emptoz A, Michel V, Lelli A, Akil O, Boutet de Monvel J, Lahlou G, Meyer A, Dupont T, Nouaille S, Ey E, Franca de Barros F, Beraneck M, Dulon D, Hardelin JP, Lustig L, Avan P, Petit C, Safieddine S (2017) Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G. *Proc Natl Acad Sci U S A* 114:9695–9700. https://doi.org/10.1073/pnas.1708894114

Fields RR, Zhou G, Huang D, Davis JR, Moller C, Jacobson SG, Kimberling WJ, Sumegi J (2002) Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations. *Am J Hum Genet* 71:607–617. https://doi.org/10.1086/342098

Friedman TB, Schultz JM, Ahmed ZM, Tsilou ET, Brewer CC (2011) Usher syndrome: hearing loss with vision loss. *Adv Otorhinolaryngol* 70:56–65. https://doi.org/10.1159/000322473

Fowler NH, El-Rashedy MI, Chishti EA, Vander Kooi CW, Maldonado RS (2021) Multimodal imaging and genetic findings in a case of ARSG-related atypical Usher syndrome. *Ophthalmic Genet* 42:338–343. https://doi.org/10.1080/13816810.2021.1891552

Fu Q, Xu M, Chen X, Sheng X, Yuan Z, Liu Y, Li H, Sun Z, Li H, Yang L, Wang K, Zhang F, Li Y, Zhao C, Sui R, Chen R (2017) CEP78 is mutated in a distinct type of Usher syndrome. *J Med Genet* 54:190–195. https://doi.org/10.1136/jmedgenet-2016-104166

Fuster-Garcia C, Garcia-Bohorquez B, Rodriguez-Munoz A, Aller E, Jaijo T, Millan JM, Garcia-Garcia G (2021) Usher Syndrome: Genetics of a Human Ciliopathy. *Int J Mol Sci.* https://doi.org/10.3390/ijms22136723

Fuster-Garcia C, Garcia-Garcia G, Gonzalez-Romero E, Jaijo T, Sequedo MD, Ayuso C, Vazquez-Manrique RP, Millan JM, Aller E (2017) USH2A gene editing using the CRISPR system. *Mol Ther Nucleic Acids* 8:529–541. https://doi.org/10.1016/j.omtn. 2017.08.003

Fuster-Garcia C, Garcia-Garcia G, Jaijo T, Blanco-Kelly F, Tian L, Hakonarson H, Ayuso C, Aller E, Millan JM (2019) Expanding the Genetic Landscape of Usher-Like Phenotypes. *Invest Ophthalmol Vis Sci* 60:4701–4710. https://doi.org/10.1167/iovs. 19-27470

Fuster-Garcia C, Garcia-Garcia G, Jaijo T, Fornes N, Ayuso C, Fernandez-Burriel M, Sanchez-De la Morena A, Aller E, Millan JM (2018) High-throughput sequencing for the molecular diagnosis of Usher syndrome reveals 42 novel mutations and consolidates

CEP250 as Usher-like disease causative. *Sci Rep* 8:17113. https://doi.org/10.1038/s41598-018-35085-0

Garcia-Garcia G, Aparisi MJ, Jaijo T, Rodrigo R, Leon AM, Avila-Fernandez A, Blanco-Kelly F, Bernal S, Navarro R, Diaz-Llopis M, Baiget M, Ayuso C, Millan JM, Aller E (2011) Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations. *Orphanet J Rare Dis* 6:65. https://doi.org/10.1186/1750-1172-6-65

Geleoc GGS, El-Amraoui A (2020) Disease mechanisms and gene therapy for Usher syndrome. *Hear Res* 394:107932. https://doi.org/10.1016/j.heares.2020.107932

Geng R, Geller SF, Hayashi T, Ray CA, Reh TA, Bermingham-McDonogh O, Jones SM, Wright CG, Melki S, Imanishi Y, Palczewski K, Alagramam KN, Flannery JG (2009) Usher syndrome IIIA gene clarin-1 is essential for hair cell function and associated neural activation. *Hum Mol Genet* 18:2748–2760

Geng R, Omar A, Gopal SR, Chen DH, Stepanyan R, Basch ML, Din-culescu A, Furness DN, Saperstein D, Hauswirth W, Lustig LR, Alagramam KN (2017) Modeling and preventing progressive hearing loss in usher syndrome III. *Sci Rep* 7:13480. https://doi.org/10.1038/s41598-017-13620-9

Gibbs D, Azarian SM, Lillo C, Kitamoto J, Klomp AE, Steel KP, Libby RT, Williams DS (2004) Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes. *J Cell Sci* 117:6473–6483

Giese APJ, Tang YQ, Sinha GP, Bowl MR, Goldring AC, Parker A, Freeman MJ, Brown SDM, Riazuddin S, Fettiplace R, Schafer WR, Frolenkov GI, Ahmed ZM (2017) CIB2 interacts with TMC1 and TMC2 and is essential for mechanotransduction in auditory hair cells. *Nat Commun* 8:43. https://doi.org/10.1038/s41467-017-00061-1

Goldmann T, Overlack N, Moller F, Belakhov V, van Wyk M, Baasov T, Wolfrum U, Nagel-Wolfrum K (2012) A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation. *EMBO Mol Med* 4:1186–1199. https://doi.org/10.1002/emmm.20120 1438

Goodyear RJ, Marcotti W, Kros CJ, Richardson GP (2005) Development and properties of stereociliary link types in hair cells of the mouse cochlea. *J Comp Neurol* 485:75–85

Grati M, Kachar B (2011) Myosin VIIa and sans localization at stereocilia upper tip-link density implicates these Usher syndrome proteins in mechanotransduction. *Proc Natl Acad Sci USA* 108:11476–11481. https://doi.org/10.1073/pnas.1104161108

Grati M, Shin JB, Weston MD, Green J, Bhat MA, Gillespie PG, Kachar B (2012) Localization of PDZD7 to the stereocilia ankle-link associates this scaffolding protein with the Usher syndrome protein network. *J Neurosci* 32:14288–14293. https://doi.org/10. 1523/INEUROSCI.3071-12.2012

Gregory FD, Bryan KE, Pangrsic T, Calin-Jageman IE, Moser T, Lee A (2011) Harmonin inhibits presynaptic Ca(v)1.3 Ca(2+) channels in mouse inner hair cells. *Nat Neurosci* 14:1109–1111

Grillet N, Xiong W, Reynolds A, Kazmierczak P, Sato T, Lillo C, Dumont RA, Hintermann E, Sczaniecka A, Schwander M, Williams D, Kachar B, Gillespie PG, Muller U (2009) Harmonin mutations cause mechanotransduction defects in cochlear hair cells. *Neuron* 62:375–387

Grotz SSJ, Wunderlich KA, Ellederova Z, Auch H, Bähr A, Runa-Vochozkova P, Plutniok J, Arnold V, Ardan T, Veith M, Santamaria G, Dhom G, Hitzl W, Kessler B, Kurome M, Zakharchenko V, Linnert J, Fischer A, Blutke A, Döring A, Suchankova S, Popelar J, May-Simera H, Augwitz KL, Andenberghe LH, Wolf E, Nagel-Wolfrum K, Motlik JM, Fischer D, Wolfrum U, Klymiuk N (2021) Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of Usher syndrome. *BioRxiv.* https://doi.org/10.1101/2021.05.31.446123
Guan J, Wang H, Lan L, Wang L, Yang J, Xie L, Yin Z, Xiong W, Zhao L, Wang D, Wang Q (2018) Novel recessive PDZD7 biallelic mutations in two Chinese families with non-syndromic hearing loss. Am J Med Genet A 176:99–106. https://doi.org/10.1002/ ajmg.a.38477

Gyorgy B, Meijer EJ, Ivanchenko MV, Tenneson K, Emond F, Hanlon KS, Indzhykulian AA, Volak A, Karavitaki KD, Tamvakologos PI, Vezina M, Berezovskii VK, Born RT, O’Brien M, Lafond JF, Arsenijevic Y, Kenna MA, Maguire CA, Corey DP (2019) Gene transfer with AAV9-PHP.B rescues hearing in a mouse model of Usher syndrome 3A and transduces hair cells in a non-human primate. Mol Ther Methods Clin Dev 13:1–13. https://doi.org/ 10.1016/j.omtm.2018.11.003

Han S, Liu X, Xie S, Gao M, Liu F, Yu S, Sun P, Wang C, Archacki S, Lu Z, Hu X, Qin Y, Qu Z, Huang Y, Lv Y, Tu J, Li J, Yimer TA, Jiang T, Tang Z, Luo D, Chen F, Liu M (2018) Knockout of ush2a gene in zebrafish causes hearing impairment and late onset rod-cone dystrophy. Hum Genet 137:779–794. https://doi. org/10.1007/s00439-018-1936-6

Herrera W, Aleman TS, Cideciyan AV, Roman AJ, Banin E, Ben-Yosef T, Gardner LM, Sumaroka A, Windsor EA, Schwartz SB, Stone EM, Liu XZ, Kimberling WJ, Jacobson SG (2008) Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene. Invest Ophthalmol vis Sci 49:2651–2660

Hope CI, Bundey S, Proops D, Fielder AR (1997) Usher syndrome in the city of Birmingham–prevalence and clinical classification. Br J Ophthalmol 81:46–53. https://doi.org/10.1136/bjo.81.1.46

Huang XF, Xiang L, Fang XL, Liu WQ, Zhuang YY, Chen ZJ, Shen RJ, Cheng W, Han RY, Zheng SS, Chen XJ, Liu X, Jin ZB (2019) Functional characterization of CEP250 variant identified in nonsyndromic retinitis pigmentosa. Hum Mutat 40:1039–1045. https://doi.org/10.1002/humu.23759

Igelman AD, Ku C, da Palma MM, Georgiou M, Schiff ER, Lam BL, Sankila EM, Ahn J, Pyers L, Vincent A, Ferraz Sallum JM, Zein WM, Oh JK, Maldonado RS, Ryu J, Tsang SH, Gorin MB, Webster AR, Michaelides M, Yang P, Pennesi ME (2021) Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome. Ophthalmic Genet 42:664–673. https://doi.org/10.1080/13816810.2021.1946704

Isgrig K, McDougald DS, Zhu J, Wang HJ, Bennett J, Chien WW (2019) AAV2.7m8 is a powerful viral vector for inner ear gene therapy. Nat Commun 10:427. https://doi.org/10.1038/ s41467-018-08243-1

Isgrig K, Shteamer JW, Belyantseva IA, Drummond MC, Fitzgerald TS, Vijayakumar S, Jones SM, Griffith AJ, Friedman TB, Cunningham LL, Chien WW (2017) Gene therapy restores balance and auditory functions in a mouse model of Usher syndrome. Mol Ther 25:780–791. https://doi.org/10.1016/j.ymthe.2017. 01.007

Jacobson SG, Cideciyan AV, Aleman TS, Sumaroka A, Roman AJ, Gardner LM, Prosser HM, Mishra M, Bech-Hansen NT, Herrera W, Schwartz SB, Liu XZ, Kimberling WJ, Steel KP, Williams DS (2008) Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. Hum Mol Genet 17:2405–2415. https://doi.org/10.1093/hmg/ddn140

Jacobson SG, Cideciyan AV, Gibbs D, Sumaroka A, Roman AJ, Ale-
man TS, Schwartz SB, Olivares MB, Russell RC, Steinberg JD,
Kenna MA, Kimberling WJ, Rehm HL, Williams DS (2011)
Retinal disease course in Usher syndrome 1B due to MYO7A
mutations. Invest Ophthalmol vis Sci 52:7924–7936. https://doi.
org/10.1167/iovs.11-8313

Jouret G, Poirsier C, Spodenkiewicz M, Jaquin C, Gouy E, Arndt C, Labrousse M, Gaillard D, Doco-Fenzy M, Lebre AS (2019) Genetics of Usher syndrome: new insights from a meta-analysis. Otol Neurotol 40:121–129. https://doi.org/10.1097/MAO.00000 00000002054

Kachar B, Parakkal M, Kurc M, Zhao Y, Gillespie PG (2000) High-resolution structure of hair-cell tip links. Proc Natl Acad Sci U S A 97:13336–13341

Kalay E, de Brouwer AP, Caylan R, Nabuurs SB, Wollnik B, Karaguzel A, Heister JG, Erdol H, Cremers FP, Cremers CW, Brunner HG, Kremer H (2005) A novel D458V mutation in the SANS PDZ binding motif causes atypical Usher syndrome. J Mol Med (berl) 83:1025–1032. https://doi.org/10.1007/s00109-005-0719-4

Khan AO, Becirovic E, Betz C, Neuhaus C, Altmuller J, Maria Ried-
mayr L, Motameny S, Nurnberg G, Nurnberg P, Bolz HJ (2017)
A deep intronic CLRN1 (USH3A) founder mutation generates
an aberrant exon and underlies severe Usher syndrome on the
Arabian Peninsula. Sci Rep 7:1411. https://doi.org/10.1038/
s41598-017-01577-8

Khan MI, Kersten FF, Azam M, Collin RW, Hussain A, Shah ST, Keunen JE, Kremer H, Cremers FP, Qamar R, den Hollander AI (2011) CLRN1 mutations cause nonsyndromic retinitis pigmentosa. Ophthalmology 118:1444–1448. https://doi.org/10.1016/j.ophtha.2010.10.047

Khateb S, Kowalewski B, Bedoni N, Damme M, Pollack N, Saada A, Obolensky A, Ben-Yosef T, Gross M, Dierks T, Banin E, Rivolta C, Sharon D (2018) A homozygous founder missense variant in arylsulfatase G abolishes its enzymatic activity causing atypical Usher syndrome in humans. Genet Med 20:1004–1012. https://doi.org/10.1038/gim.2017.227

Khateb S, Mohand-Saïd S, Nassisi M, Bonnet C, Roux A, Andrieu C, Antonio A, Condroyer C, Zeitz C, Devisme C, Loundon N, Marlin S, Petit C, Bodaghi B, Sahel J, Audo I (2019) Phenotypic characteristics of rod-cone dystrophy associated with MYO7A mutations in a large French cohort. Retina. https://doi.org/10.1097/IAE.0000000000002636

Khateb S, Zelinger L, Mizrahi-Meissonnier L, Ayuso C, Koenekoop RK, Laxer U, Gross M, Banin E, Sharon D (2014) A homozygous nonsense CEP250 mutation combined with a heterozygous nonsense C2orf71 mutation is associated with atypical Usher syndrome. J Med Genet 51:460–469. https://doi.org/10.1136/jmedgenet-2014-102287

Kimberling WJ, Hildebrand MS, Shearer AE, Jensen ML, Halder JA, Trzupek K, Cohn ES, Weleber RG, Stone EM, Smith RJ (2010) Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children. Genet Med 12:512–516. https://doi.org/10.1097/GIM.0b013e3181e5afb8

Kowalewski B, Heimann P, Ortkras T, Lullmann-Rauch R, Sawada T, Walkley SU, Dierks T, Damme M (2015) Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III). Hum Mol Genet 24:1856–1868. https://doi.org/10.1093/hmg/ddu603

Kremer H, van Wijk E, Marker T, Wolfrum U, Roepman R (2006) Usher syndrome: molecular links of pathogenesis, proteins and pathways. Hum Mol Genet. https://doi.org/10.1093/hmg/ddl205

Kruszewski K, Lullmann-Rauch R, Dierks T, Bartsch U, Damme M (2016) Degeneration of photoreceptor cells in arylsulfatase G-Deficient mice. Invest Ophthalmol vis Sci 57:1120–1131. https://doi.org/10.1167/iovs.15-17645

Kubota D, Gocho K, Kikuchi S, Akeo K, Miura M, Yamaki K, Takahashi H, Kameya S (2018) CEP250 mutations associated with mild cone-rod dystrophy and sensorineural hearing loss in a Japanese family. Ophthalmic Genet 39:500–507. https://doi.org/10.1080/13816810.2018.1466338

Kumar A, Rajendran V, Sethumadhavan R, Purohit R (2013) CEP proteins: the knights of centrosome dynasty. Protoplasma 250:965–983. https://doi.org/10.1007/s00709-013-0488-9
Landegger LD, Pan B, Askew C, Wassmer SJ, Gluck SD, Galvin A, Taylor R, Forge A, Stankovic KM, Holt JR, Vandenberghe LH (2017) A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear. Nat Biotechnol 35:280–284. https://doi.org/10.1038/nbt.3781

Lee SY, Han JH, Kim BJ, Oh SH, Lee S, Oh DY, Choi BY (2019) Identification of a potential founder effect of a novel PDZD7 variant involved in moderate-to-severe sensorineural hearing loss in Koreans. Int J Mol Sci. https://doi.org/10.3390/ijms20174174

Lefevre G, Michel V, Weil D, Lepelletier L, Bizard E, Wolfrum U, Hardelin JP, Petit C (2008) A core cochlear phenotype in USH1 mouse mutants implicates fibrous links of the hair bundle in its cohesion, orientation and differential growth. Development 135:1427–1437. https://doi.org/10.1242/dev.012922

Lenarduzzi S, Morgan A, Faletra F, Cappellani S, Morgutti M, Mez- zavilla M, Peruzzi A, Ghiselli S, Ambrosetti U, Graziano C, Seri M, Gasparini P, Girotto G (2019) Next generation sequencing study in a cohort of Italian patients with syndromic hearing loss. Hear Res 381:107769. https://doi.org/10.1016/j.heares.2019.07.006

Lenassi E, Vincent A, Li Z, Saihan Z, Coffey AJ, Steele-Stallard HB, Moore AT, Steel KP, Luxon LM, Heon E, Bitner-Glindzicz M, Webster AR (2015) A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants. Eur J Hum Genet 23:1318–1327. https://doi.org/10.1038/ejhg.2014.283

Lentz JJ, Jodelka FM, Hinrich AJ, McCaffrey KE, Farris HE, Spalitta MJ, Bazan NG, Duelli DM, Rigo F, Hastings ML (2013) Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nat Med 19:345–350. https://doi.org/10.1038/nm.3106

Lentz JJ, Pan B, Ponnath A, Tran CM, Nist-Lund C, Galvin A, Gold- berg H, Robillard KN, Jodelka FM, Farris HE, Huang J, Chen T, Zhu H, Zhou W, Rigo F, Hastings ML, Geleoc GSG (2020) Direct delivery of antisense oligonucleotides to the middle and inner ear improves hearing and balance in Usher mice. Mol Ther 28:2662–2676. https://doi.org/10.1016/j.ymthe.2020.08.002

Li T, Feng Y, Liu Y, He C, Liu J, Chen H, Deng Y, Li M, Li W, Song J, Niu Z, Sang S, Wen J, Men M, Chen X, Li J, Liu X, Ling J (2019) A novel ABHD12 nonsense variant in Usher syndrome type 3 family with genotype-phenotype spectrum review. Gene 704:113–120. https://doi.org/10.1016/j.gene.2019.04.008

Liang X, Qiu X, Dionne G, Cunningham CL, Pucak ML, Peng G, Kim YH, Lauer A, Shapiro L, Muller U (2021) CIB2 and CIB3 are auxiliary subunits of the mechanotransduction channel of hair cells. Neuron 109(2131–2149):e15. https://doi.org/10.1016/j.neuron.2021.05.007

Liu X, Ondek B, Williams DS (1998a) Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice. Nature Genet 19:117–118

Liu X, Udovichenko IP, Brown SD, Steel KP, Williams DS (1999a) Myosin VIIa participates in opsin transport through the photo- receptor cilium. J Neurosci 19:6267–6274

Liu X, Vansant G, Udovichenko IP, Wolfrum U, Williams DS (1997a) Myosin VIIa, the product of the Usher 1B syndrome gene, is concentrated in the connecting cilia of photoreceptor cells. Cell Motil Cytoskeleton 37:240–252

Liu XZ, Hope C, Liang CY, Zou JM, Xu LR, Cole T, Mueller RF, Bundey S, Nance W, Steel KP, Brown SD (1999b) A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. Am J Hum Genet 64:1221–1225. https://doi.org/10.1086/302332

Liu XZ, Hope C, Walsh J, Newton V, Ke XM, Liang CY, Xu LR, Zhou JM, Trump D, Steel KP, Bundey S, Brown SD (1998b) Mutations in the myosin VIIA gene cause a wide phenotypic

spectrum, including atypical Usher syndrome. Am J Hum Genet 63:909–912. https://doi.org/10.1086/302026

Liu XZ, Walsh J, Mburu P, Kendrick-Jones J, Cope MJ, Steel KP, Brown SD (1997b) Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet 16:188–190. https://doi.org/10.1038/ng0697-188

Liu XZ, Walsh J, Tamagawa Y, Kitamura K, Nishizawa M, Steel KP, Brown SD (1997c) Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet 17:268–269. https://doi.org/10.1038/ng1197-268

Lopes VS, Gibbs D, Libby RT, Aleman TS, Welch DL, Lillo C, Jacobson SG, Radu RA, Steel KP, Williams DS (2011) The Usher 1B protein, MYO7A, is required for normal localization and function of the visual retinoid cycle enzyme, RPE65. Hum Mol Genet 20:2560–2570

Loundon N, Marlin S, Busquet D, Denoyelle F, Roger G, Renaud F, Garabedian EN (2003) Usher syndrome and cochlear implantation. Otol Neurotol 24:216–221

Lustig L, Akil O (2019) Cochlear gene therapy. Cold Spring Harb Perspect Med. https://doi.org/10.1101/cshperspect.a033191

Luo H, Hassan RN, Yan J, Xie J, Du P, Hu Q, Zhu Y, Jiang W (2019) Novel recessive PDZD7 biallelic mutations associated with hereditary hearing loss in a Chinese pedigree. Gene 709:65–74. https://doi.org/10.1016/j.gene.2019.05.045

Maerker T, van Wijk E, Overlack N, Kersten FF, McGee J, Gold- mann T, Sehn E, Roepman R, Walsh EJ, Kremer H, Wolfrum U (2008) A novel Usher protein network at the periciliary reloading point between molecular transport machineries in verte- brate photoreceptor cells. Hum Mol Genet 17:71–86. https:// doi.org/10.1093/hmg/ddm285

Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, Marshall KA, McCague S, Reichert H, Davis M, Simonelli F, Leroy BP, Wright JF, High KA, Bennett J (2019) Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials. Ophthalmology 126:1273–1285. https://doi.org/10.1016/j.ophtha.2019.06.017

Malm E, Ponjavic V, Moller C, Kimberling WJ, Stone ES, Andreas- son S (2011) Alteration of rod and cone function in children with Usher syndrome. Eur J Ophthalmol 21:30–38. https://doi. org/10.5301/ejo.2010.5433

Maria Oonk AM, van Huet RA, Leijendeckers JM, Oostrik J, Vense- laar H, van Wijk E, Beynon A, Kunst HP, Hoyng CB, Kremer H, Schraders M, Pennings RJ (2015) Nonsyndromic hearing loss caused by USH1G mutations: widening the USH1G dis- ease spectrum. Ear Hear 36:205–211. https://doi.org/10.1097/ AUD.00000000000000095

Marouf A, Johnson B, Alagramam KN (2022) Usher syndrome IIIA: a review of the disorder and preclinical research advances in therapeutic approaches. Hum Genet. https://doi.org/10.1007/ s00439-022-02446-9

Mathur P, Yang J (2015) Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities. Biochim Biophys Acta 1852:406–420. https://doi.org/10.1016/j.bbadis.2014.11. 020

Mathur PD, Yang J (2019) Usher syndrome and non-syndromic deaf- ness: functions of different whirlin isoforms in the cochlea, ves- tibular organs, and retina. Hear Res 375:14–24. https://doi.org/ 10.1016/j.heares.2019.02.007

Mburu P, Mustapha M, Varela A, Weil D, El-Amraoui A, Holme RH, Rump A, Hardisty RE, Blanchard S, Coimbra RS, Perfettini I, Parkinson N, Mallon AM, Glenister P, Rogers MJ, Paige AJ, Moir L, Clay J, Rosenthal A, Liu XZ, Blanco G, Steel KP, Petit C, Brown SD (2003) Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler
mouse and families with DFNB31. Nat Genet 34:421–428.
https://doi.org/10.1038/ng1208

McGee J, Goodyear RJ, McMillan DR, Stauffer EA, Holt JR, Locke
KG, Birch DG, Legan PK, White PC, Walsh EJ, Richardson GP
(2006) The very large G-protein-coupled receptor VLGR1: a
component of the ankle link complex required for the normal
development of auditory hair bundles. J Neurosci 26:6543–6553

Michalski N, Michel V, Bahloul A, Lefèvre G, Barral J, Yagi H, Chard-
enoux S, Weil D, Martin P, Hardelin J-P, Sato M, Petit C (2007)
Molecular characterization of the ankle link complex in cochlear
hair cells and its role in the hair bundle functioning. J Neurosci
27:6478–6488

Michalski N, Michel V, Caberlotto E, Lefevre GM, van Aken AF, Tinevez JY, Bizard E, Houbron C, Weil D, Hardelin JP, Richardson GP, Kros CJ, Martin P, Petit C (2009) Harmonin-b, an actin-binding scaffold protein, is involved in the adaptation of mechanoelectrical transduction by sensory hair cells. Pflügers Arch 459:115–130. https://doi.org/10.1007/s00424-009-0711-x

Michalski N, Petit C (2019) Genes involved in the development and
physiology of both the peripheral and central auditory systems.
Annu Rev Neurosci 42:67–86. https://doi.org/10.1146/annur
ev-neuro-070918-050428

Michel V, Booth KT, Patni P, Cortese M, Azaiez H, Bahloul A, Kahrizi K, Labbe M, Emtoz A, Lelli A, Degardin J, Dupont T, Aghaie A, Oficjalska-Pham D, Picaud S, Najmabadi H, Smith RJ, Bowl MR, Brown SD, Avan P, Petit C, El-Amraoui A (2017) CIB2, defective in isolated deafness, is key for auditory hair cell mechanotransduction and survival. EMBO Mol Med 9:1711–1731. https://doi.org/10.15252/emmm.201708087

Miles A, Blair C, Emili A, Tropepe V (2021) Usher syndrome type 1-associated gene, pcdh15b, is required for photoreceptor structural integrity in zebrafish. Dis Model Mech. https://doi.org/10.1242/dmm.048965

Millan JM, Aller E, Jaijo T, Blanco-Kelly F, Gimenez-Pardo A, Ayuso C (2011) An update on the genetics of usher syndrome. J Ophthalmol 2011:417217. https://doi.org/10.1155/2011/417217

Morgan CP, Krey JF, Grati M, Zhao B, Fallen S, Kannan-Sundhari A, Liu XZ, Choi D, Muller U, Barr-Gillespie PG (2016) PDZD7-MY07A complex identified in enriched stereocilia membranes. Elife. https://doi.org/10.7554/eLife.18312

Nagel-Wolfrum K, Moller F, Penner I, Baasov T, Wolfrum U (2016) Targeting nonsense mutations in diseases with translational read-through-inducing drugs (TRIDs). BioDrugs 30:49–74. https://doi.org/10.1007/s40259-016-0157-6

Namburi P, Ratnapriya R, Khateb S, Lazar CH, Kinarty Y, Obolensky A, Erdinest I, Marks-Ohana D, Pras E, Ben-Yosef T, Newman H, Gross M, Swaroop A, Banin E, Sharon D (2016) Bi-allelic truncating mutations in CEP78, encoding centrosomal protein 78, cause cone-rod degeneration with sensorineural hearing loss. Am J Hum Genet 99:1222–1223. https://doi.org/10.1016/j.ajhg.2016.09.012

Naz S, Griffith AJ, Riazuddin S, Hampton LL, Battey JF Jr, Khan SN, Riazuddin S, Wilcox ER, Friedman TB (2004) Mutations of ESPN cause autosomal recessive deafness and vestibular dysfunction. J Med Genet 41:591–595. https://doi.org/10.1136/jmg.2004.018523

Ness SL, Ben-Yosef T, Bar-Lev A, Madeo AC, Brewer CC, Avraham
KB, Kornreich R, Desnick RJ, Willner JP, Friedman TB, Grif-
fith AJ (2003) Genetic homogeneity and phenotypic variability
among Ashkenazi Jews with Usher syndrome type III. J Med
Genet 40:767–772

Neuhaus C, Eisenberger T, Decker C, Nagl S, Blank C, Pfister M, Ken-
nerknecht I, Muller-Hofstede C, Charbel Issa P, Heller R, Beck
B, Ruther K, Mitter D, Rohrschneider K, Steinhauer U, Korb-
macher HM, Huhle D, Elsayed SM, Taha HM, Baig SM, Stohr

H, Preising M, Markus S, Moeller F, Lorenz B, Nagel-Wolfrum K, Khan AO, Bolz HJ (2017) Next-generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read-through, and PEX26 mutated in Heimler syndrome. Mol Genet Genomic Med 5:531–552.
https://doi.org/10.1002/mgg3.312

Nikopoulos K, Farinelli P, Giangreco B, Tsika C, Royer-Bertrand B, Mbefo MK, Bedoni N, Kjellstrom U, El Zaoui I, Di Gioia SA, Balzano S, Cisarova K, Messina A, Decembrini S, Plainis S, Blazaki SV, Khan MI, Micheal S, Boldt K, Ueffing M, Moul- lin AP, Cremers FPM, Roepman R, Arsenijevic Y, Tsilimbaris MK, Andreasson S, Rivolta C (2016) Mutations in CEP78 cause cone-rod dystrophy and hearing loss associated with primary- cilia defects. Am J Hum Genet 99:770–776. https://doi.org/10. 1016/j.ajhg.2016.07.009

Nisenbaum E, Thielhelm TP, Nourbakhsh A, Yan D, Blanton SH, Shu Y, Koehler KR, El-Amraoui A, Chen Z, Lam BL, Liu X (2021) Review of genotype-phenotype correlations in Usher syndrome. Ear Hear. https://doi.org/10.1097/AUD.0000000000001066

Nishiguchi KM, Avila-Fernandez A, van Huet RA, Corton M, Perez-Carro R, Martin-Garrido E, Lopez-Molina MI, Blanco-Kelly F, Hoefsloot LH, van Zelst-Stams WA, Garcia-Ruiz PJ, Del Val J, Di Gioia SA, Klevering BJ, van de Warrenburg BP, Vazquez C, Cremers FP, Garcia-Sandoval B, Hoyng CB, Collin RW, Rivolta C, Ayuso C (2014) Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: from syndromic to nonsyndromic retinal degeneration. Ophthalmology 121:1620–1627.
https://doi.org/10.1016/j.ophtha.2014.02.008

Nolen RM, Hufnagel RB, Friedman TB, Turriff AE, Brewer CC, Zalewski CK, King KA, Wafa TT, Griffith AJ, Brooks BP, Zein WM (2020) Atypical and ultra-rare Usher syndrome: a review. Ophthalmic Genet 41:401–412. https://doi.org/10.1080/13816 810.2020.1747090

Orchard S, Kerrien S, Abbani S, Aranda B, Bhate J, Bidwell S, Bridge A, Briganti L, Brinkman FS, Cesareni G, Chatr-aryamontri A, Chautard E, Chen C, Dumousseau M, Goll J, Hancock RE, Han- nick LI, Jurisica I, Khadake J, Lynn DJ, Mahadevan U, Perfetto L, Raghunath A, Ricard-Blum S, Roechert B, Salwinski L, Stumpflen V, Tyers M, Uetz P, Xenarios I, Hermjakob H (2012) Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. Nat Methods 9:345–350. https:// doi.org/10.1038/nmeth.1931

Ouyang XM, Xia XJ, Verpy E, Du LL, Pandya A, Petit C, Balkany T, Nance WE, Liu XZ (2002) Mutations in the alternatively spliced exons of USH1C cause non-syndromic recessive deafness. Hum Genet 111:26–30. https://doi.org/10.1007/s00439-002-0736-0

Ouyang XM, Yan D, Du LL, Hejtmancik JF, Jacobson SG, Nance WE, Li AR, Angeli S, Kaiser M, Newton V, Brown SD, Balkany T, Liu XZ (2005) Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population. Hum Genet 116:292–299. https://doi.org/10.1007/s00439-004-1227-2

Overlack N, Goldmann T, Wolfrum U, Nagel-Wolfrum K (2012) Gene repair of an Usher syndrome causing mutation by zinc-finger nuclease mediated homologous recombination. Invest Ophthal- mol vis Sci 53:4140–4146. https://doi.org/10.1167/iovs.12-9812

Pan B, Askew C, Galvin A, Heman-Ackah S, Asai Y, Indzykulian AA, Jodelka FM, Hastings ML, Lentz JJ, Vandenberghe LH, Holt JR, Geleoc GS (2017) Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c. Nat Biotechnol 35:264–272. https://doi.org/10.1038/nbt.3801

Patel K, Giese AP, Grossheim JM, Hegde RS, Delio M, Samanich J, Riazuddin S, Frolenkov GI, Cai J, Ahmed ZM, Morrow BE (2015) A Novel C-Terminal CIB2 (Calcium and Integrin Binding Protein 2) Mutation Associated with Non-Syndromic Hearing
Loss in a Hispanic Family. PLoS ONE 10:e0133082. https://doi.org/10.1371/journal.pone.0133082

Peng YW, Zallocchi M, Wang WM, Delimont D, Cosgrove D (2011) Moderate light-induced degeneration of rod photoreceptors with delayed transducin translocation in shaker1 mice. Invest Ophthal-mol vis Sci 52:6421–6427. https://doi.org/10.1167/iovs.10-6557

Peters KR, Palade GE, Schneider BG, Papermaster DS (1983) Fine structure of a periciliary ridge complex of frog retinal rod cells revealed by ultrahigh resolution scanning electron microscopy. J Cell Biol 96:265–276

Peter VG, Quinodoz M, Sadio S, Held S, Rodrigues M, Soares M, Sousa AB, Coutinho Santos L, Damme M, Rivolta C (2021) New clinical and molecular evidence linking mutations in ARSG to Usher syndrome type IV. Hum Mutat 42:261–271. https://doi.org/10.1002/humu.24150

Petit C, Richardson G (2009) Linking deafness genes to hair-bundle development and function. Nat Neurosci 12:703–710

Pierrache LH, Hartel BP, van Wijk E, Meester-Smoor MA, Cremers FP, de Baere E, de Zaeytijd J, van Schooneveld MJ, Cremers CW, Dagnelie G, Hoyng CB, Bergen AA, Leroy BP, Pennings RJ, van den Born LI, Klaver CC (2016) Visual prognosis in USH2A-associated retinitis pigmentosa is worse for patients with Usher syndrome type IIa than for those with nonsyndromic retinitis pigmentosa. Ophthalmology 123:1151–1160. https://doi.org/10.1016/j.ophtha.2016.01.021

Puffenberger EG, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP, Cassidy RP, Fiorentini CJ, Heiken KF, Lawrence JJ, Mahoney MH, Miller CJ, Nair DT, Politi KA, Worcester KN, Setton RA, Dipiazza R, Sherman EA, Eastman JT, Francklyn C, Robey-Bond S, Rider NL, Gabriel S, Morton DH, Strauss KA (2012) Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS ONE 7:e28936. https://doi.org/10.1371/journal.pone.0028936

Reiners J, Nagel-Wolfrum K, Jurgens K, Marker T, Wolfrum U (2006) Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res 83:97–119. https://doi.org/10.1016/j.exer.2005.11.010

Riazuddin S, Belyantseva IA, Giese AP, Lee K, Indzhykulian AA, Nandamuri SP, Yousaf R, Sinha GP, Lee S, Terrell D, Hegde RS, Ali RA, Anwar S, Andrade-Elizondo PB, Sirmaci A, Parise LV, Basit S, Wali A, Ayub M, Ansar M, Ahmad W, Khan SN, Akram J, Tekin M, Riazuddin S, Cook T, Buschbeck EK, Frolenkov GI, Leal SM, Friedman TB, Ahmed ZM (2012) Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48. Nat Genet 44:1265–1271. https://doi.org/10.1038/ng.2426

Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, McCague S, Cross D, Marshall KA, Walshie J, Kehoe TL, Reichert H, Davis M, Raffini L, George LA, Hudson FP, Dingfield L, Zhu X, Haller JA, Sohn EH, Mahajan VB, Pfeifer W, Weckmann M, Johnson C, Gewaily D, Drack A, Stone E, Wachtel K, Simonelli F, Leroy BP, Wright JF, High KA, Maguire AM (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390:849–860. https://doi.org/10.1016/S0140-6736(17)31868-8

Sahel JA, Bennett J, Roska B (2019) Depicting brighter possibilities for treating blindness. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aax2324

Sahly I, Dufour E, Schietroma C, Michel V, Bahloul A, Perfettini I, Pepermans E, Estivalet A, Carette D, Aghaie A, Ebermann I, Lelli A, Iribarne M, Hardelin JP, Weil D, Sahel JA, El-Amraoui A, Petit C (2012) Localization of Usher 1 proteins to the

photoreceptor calyceal processes, which are absent from mice. J Cell Biol 199:381–399. https://doi.org/10.1083/jcb.201202012

Sahly I, El-Amraoui A, Abitbol M, Petit C, Dufier JL (1997) Expression of myosin VIIA during mouse embryogenesis. Anat Embryol (berl) 196:159–170. https://doi.org/10.1007/s004290050088

Schietroma C, Parain K, Estivalet A, Aghaie A, Boutet de Monvel J, Picaud S, Sahel JA, Perron M, El-Amraoui A, Petit C (2017) Usher syndrome type 1-associated cadherins shape the photo-receptor outer segment. J Cell Biol 216:1849–1864. https://doi.org/10.1083/jcb.201612030

Schneider E, Marker T, Daser A, Frey-Mahn G, Beyer V, Farcas R, Schneider-Ratzke B, Kohlschmidt N, Grossmann B, Bauss K, Napiontek U, Keilmann A, Bartsch O, Zechner U, Wolfrum U, Haaf T (2009) Homozygous disruption of PDZD7 by reciprocal translocation in a consanguineous family: a new member of the Usher syndrome protein interactome causing congenital hearing impairment. Hum Mol Genet 18:655–666. https://doi.org/10.1093/hmg/ddn395

Seco CZ, Giese AP, Shafique S, Schraders M, Oonk AM, Grossheim M, Oostrik J, Strom T, Hegde R, van Wijk E, Frolenkov GI, Azam M, Yntema HG, Free RH, Riazuddin S, Verheij JB, Admiraal RJ, Qamar R, Ahmed ZM, Kremer H (2016) Novel and recurrent CIB2 variants, associated with nonsyndromic deafness, do not affect calcium buffering and localization in hair cells. Eur J Hum Genet 24:542–549. https://doi.org/10.1038/ejhg.2015.157

Sekerkova G, Zheng L, Loomis PA, Mugnaini E, Bartles JR (2006) Espins and the actin cytoskeleton of hair cell stereocilia and sensory cell microvilli. Cell Mol Life Sci 63:2329–2341. https://doi.org/10.1007/s00018-006-6148-x

Senften M, Schwander M, Kazmierczak P, Lillo C, Shin JB, Hasson T, Geleoc GS, Gillespie PG, Williams D, Holt JR, Muller U (2006) Physical and functional interaction between protocadherin 15 and myosin VIIa in mechanosensory hair cells. J Neurosci 26:2060–2071

Sethna S, Scott PA, Giese APJ, Duncan T, Jian X, Riazuddin S, Ranzazzo PA, Redmond TM, Bernstein SL, Riazuddin S, Ahmed ZM (2021a) CIB2 regulates mTORC1 signaling and is essential for autophagy and visual function. Nat Commun 12:3906. https://doi.org/10.1038/s41467-021-24056-1

Sethna S, Zein WM, Riaz S, Giese AP, Schultz JM, Duncan T, Hufnagel RB, Brewer CC, Griffith AJ, Redmond TM, Riazuddin S, Friedman TB, Ahmed ZM (2021b) Proposed therapy, developed in a Pcdh15-deficient mouse, for progressive loss of vision in human Usher syndrome. Elife. https://doi.org/10.7554/eLife.67361

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504. https://doi.org/10.1101/gr.1239303

Siemens J, Kazmierczak P, Reynolds A, Sticker M, Littlewood-Evans A, Muller U (2002) The Usher syndrome proteins cadherin 23 and harmonin form a complex by means of PDZ-domain interactions. Proc Natl Acad Sci U S A 99:14946–14951

Souissi A, Ben Said M, Ben Ayed I, Elloumi I, Bouzid A, Mosrati MA, Hasnaoui M, Belcadhi M, Idriss N, Kamoun H, Gharbi N, Gibriel AA, Tlili A, Masmoudi S (2021) Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population. J Adv Res 31:13–24. https://doi.org/10.1016/j.jare.2021.01.005

Steele-Stallard HB, Le Quesne SP, Lenassi E, Luxon LM, Claustres M, Roux AF, Webster AR, Bitner-Glindzicz M (2013) Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing. Orphanet J Rare Dis 8:122. https://doi.org/10.1186/1750-1172-8-122
Stiff HA, Sloan-Heggen CM, Ko A, Pfeifer WL, Kolbe DL, Nishimura CJ, Frees KL, Booth KT, Wang D, Weaver AE, Azaicz H, Kamholz J, Smith RJH, Drack AV (2020) Is it Usher syndrome? Collaborative diagnosis and molecular genetics of patients with visual impairment and hearing loss. *Ophthalmic Genet* 41:151–158. https://doi.org/10.1080/13816810.2020.1747088

Sun T, Xu K, Ren Y, Xie Y, Zhang X, Tian L, Li Y (2018) Comprehensive molecular screening in Chinese usher syndrome patients. *Invest Ophthalmol vis Sci* 59:1229–1237. https://doi.org/10.1167/iovs.17-23312

Tian G, Lee R, Ropelewski P, Imanishi Y (2016) Impairment of vision in a mouse model of Usher syndrome type III. *Invest Ophthalmol vis Sci* 57:866–875. https://doi.org/10.1167/iovs.15-16946

Tiwari A, Bahr A, Bahr L, Fleischhauer J, Zinkernagel MS, Winkler N, Barthelmes D, Berger L, Gerth-Kahlert C, Neidhardt J, Berger W (2016) Next generation sequencing based identification of disease-associated mutations in Swiss patients with retinal dystrophies. *Sci Rep* 6:28755. https://doi.org/10.1038/srep28755

Toms M, Dubis AM, de Vrieze E, Tracey-White D, Mitsios A, Hayes M, Broekman S, Baxendale S, Utoomprurkporn N, Bamiou D, Bitner-Glindzicz M, Webster AR, Van Wijk E, Moosajee M (2020a) Clinical and preclinical therapeutic outcome metrics for USH2A-related disease. *Hum Mol Genet*. https://doi.org/10.1093/hmg/ddaa004

Toms M, Pagarkar W, Moosajee M (2020b) Usher syndrome: clinical features, molecular genetics and advancing therapeutics. *Ther Adv Ophthalmol* 12:2515841420952194. https://doi.org/10.1177/2515841420952194

Toualbi L, Toms M, Moosajee M (2020) USH2A-retinopathy: from genetics to therapeutics. *Exp Eye Res* 201:108330. https://doi.org/10.1016/j.exer.2020.108330

DE Trouillet A, Dégardin J, Estivalet A, Ivkovic I, Godefroy D, García-Ayuso D, Simonutti M, Sahly I, Sahel JA, El-Amraoui A, Petit C, Picaud S (2018) Cone degeneration is triggered by the absence of USH1 proteins but prevented by antioxi-dant treatments. *Sci Rep* 8:1968. https://doi.org/10.1038/s41598-018-20171-0

Ulshafer RJ, Spoerri PE, Allen CB, Kelley KC (1987) Scanning electron microscopic observations on differentiation and maintenance of photoreceptor cells in vitro. *Scanning Microsc* 1:241–246

Van Aarem A, Wagenaar M, Pinckers AJ, Huygen PL, Bleeker-Wagemakers EM, Kimberling BJ, Cremers CW (1995) Ophthalmologic findings in Usher syndrome type 2A. *Ophthalmic Genet* 16:151–158. https://doi.org/10.3109/13816819509057856

van Wijk E, Pennings RJ, te Brinke H, Claassen A, Yntema HG, Hoefsloot LH, Cremers FP, Cremers CW, Kremer H (2004) Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. *Am J Hum Genet* 74:738–744

Velez-Ortega AC, Freeman MJ, Indzhykulian AA, Grossheim JM, Frolenkov GI (2017) Mechanotransduction current is essential for stability of the transducing stereocilia in mammalian auditory hair cells. *Elife*. https://doi.org/10.7554/eLife.24661

Velde HM, Reurink J, Held S, Li CHZ, Yzer S, Oostrik J, Weeda J, Haer-Wigman L, Yntema HG, Roosing S, Pauleikhoff L, Lange C, Whelan L, Dockery A, Zhu J, Keegan DJ, Farrar GJ, Kremer H, Lanting CP, Damme M, Pennings RJE (2022) Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants. *Hum Genet*. https://doi.org/10.1007/s00439-022-02441-0

Verpy E, Leibovici M, Zwaenepoel I, Liu X-Z, Gal A, Salem N, Mansour A, Blanchard S, Kobayashi I, Keats BJB, Slim R, Petit C (2000) A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. *Nature Genet* 26:51–55

Verschueren ABL, Ferrari U, Fouquet S, Nouvel-Jaillard C, Paques M, Picaud S, Sahel JA (2021) Planar polarity in primate cone photoreceptors: a potential role in Stiles Crawford effect phototropism. *Commun Biol*. https://doi.org/10.1038/s42003-021-02998-y

Vona B, Lechno S, Hofrichter MA, Hopf S, Laig AK, Haaf T, Keilmann A, Zechner U, Bartsch O (2016) Confirmation of PDZD7 as a nonsyndromic hearing loss gene. *Ear Hear* 37:e238–e246. https://doi.org/10.1097/AUD.00000000000000278

Wang L, Zou J, Shen Z, Song E, Yang J (2012) Whirlin interacts with espin and modulates its actin-regulatory function: an insight into the mechanism of Usher syndrome type II. *Hum Mol Genet* 21:692–710. https://doi.org/10.1093/hmg/ddr503

Wang Y, Li J, Yao X, Li W, Du H, Tang M, Xiong W, Chai R, Xu Z (2017) Loss of CIB2 causes profound hearing loss and abolishes mechanoelectrical transduction in mice. *Front Mol Neurosci* 10:401. https://doi.org/10.3389/fnmol.2017.00401

Watanabe N, Miyake Y, Wakabayashi T, Usukura J (1999) Periciliary structure of developing rat photoreceptor cells. A deep etch replica and freeze substitution study. *J Electron Microsc* (tokyo) 48:929–935

Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A, Levilliers J, Weston MD, Kelley PM, Kimberling WJ, Wagenaar M, Levi-Acobas F, Larget-Piet D, Munnich A, Steel KP, Brown SDM, Petit C (1995) Defective myosin VIIA gene responsible for Usher syndrome type 1B. *Nature* 374:60–61

Weil D, El-Amraoui A, Masmoudi S, Mustapha M, Kikkawa Y, Lainé S, Delmaghani S, Adato A, Nadifi S, BenZina Z, Hamel C, Gal A, Ayadi H, Yonekawa H, Petit C (2003) Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. *Hum Mol Genet* 12:463–471

Weil D, Kussel P, Blanchard S, Levy G, Levi-Acobas F, Drira M, Ayadi H, Petit C (1997) The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. *Nat Genet* 16:191–193. https://doi.org/10.1038/ng0697-191

Weston MD, Eudy JD, Fujita S, Yao S, Usami S, Cremers C, Greenberg J, Ramesar R, Martini A, Moller C, Smith RJ, Sumegi J, Kimberling WJ (2000) Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. *Am J Hum Genet* 66:1199–1210

Weston MD, Luijendijk MW, Humphrey KD, Moller C, Kimberling WJ (2004) Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II. *Am J Hum Genet* 74:357–366

Williams DS (2002) Transport to the photoreceptor outer segment by myosin VIIa and kinesin II. *Vision Res* 42:455–462

Williams DS, Chadha A, Hazim R, Gibbs D (2017) Gene therapy approaches for prevention of retinal degeneration in Usher syndrome. *Gene Ther* 24:68–71. https://doi.org/10.1038/gt.2016.81

Yagi H, Tokano H, Maeda M, Takabayashi T, Nagano T, Kiyama H, Fujieda S, Kitamura K, Sato M (2007) Vlgr1 is required for proper stereocilia maturation of cochlear hair cells. *Genes Cells* 12:235–250

Yang J, Liu X, Zhao Y, Adamian M, Pawlyk B, Sun X, McMillan DR, Liberman MC, Li T (2010) Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss. *PLoS Genet* 6:e1000955. https://doi.org/10.1371/journal.pgen.1000955

Yoshimura H, Hashimoto T, Murata T, Fukushima K, Sugaya A, Nishio SY, Usami S (2015) Novel ABHD12 mutations in PHARC patients: the differential diagnosis of deaf-blindness. *Ann Otol Rhinol Laryngol 124* (Suppl 1):77S-83S. https://doi.org/10.1177/0003489415574513

Young RW (1967) The renewal of photoreceptor cell outer segments. *J Cell Biol* 33:61–72
Young RW (1974) Proceedings: biogenesis and renewal of visual cell outer segment membranes. Exp Eye Res 18:215–223

Zhang N, Wang J, Liu S, Liu M, Jiang F (2018) Identification of two novel compound heterozygous mutations of ADGRV1 in a Chinese family with Usher syndrome type IIC. Ophthalmic Genet 39:517–521. https://doi.org/10.1080/13816810.2018.1479430

Zheng L, Sekerkova G, Vranich K, Tilney LG, Mugnaini E, Bartles JR (2000) The deaf jerker mouse has a mutation in the gene encoding the espin actin-bundling proteins of hair cell stereocilia and lacks espins. Cell 102:377–385. https://doi.org/10.1016/s0092-8674(00)00042-8

Zong L, Chen K, Wu X, Liu M, Jiang H (2016) Compound heterozygous MYO7A mutations segregating Usher syndrome type 2 in a Han family. Int J Pediatr Otorhinolaryngol 90:150–155. https://doi.org/10.1016/j.ijporl.2016.09.010

Zou J, Luo L, Shen Z, Chiodo VA, Ambati BK, Hauswirth WW, Yang J (2011) Whirlin replacement restores the formation of

the USH2 protein complex in whirlin knockout photoreceptors. Invest Ophthalmol vis Sci 52:2343–2351. https://doi.org/10.1167/iovs.10-6141

Zou J, Zheng T, Ren C, Askew C, Liu XP, Pan B, Holt JR, Wang Y, Yang J (2014) Deletion of PDZD7 disrupts the Usher syndrome type 2 protein complex in cochlear hair cells and causes hearing loss in mice. Hum Mol Genet 23:2374–2390. https://doi.org/10.1093/hmg/ddt629

**Publisher's Note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.